Transcriptional	O
activation	O
of	O
the	O
vascular	B-DNA
cell	I-DNA
adhesion	I-DNA
molecule-1	I-DNA
gene	I-DNA
in	O
T	B-cell_type
lymphocytes	I-cell_type
expressing	O
human	B-protein
T-cell	I-protein
leukemia	I-protein
virus	I-protein
type	I-protein
1	I-protein
Tax	I-protein
protein	I-protein
.	O

Recruitment	O
and	O
extravasation	O
of	O
T	B-cell_type
cells	I-cell_type
through	O
the	O
blood-brain	O
barrier	O
are	O
favored	O
by	O
adhesion	B-protein
molecule	I-protein
-mediated	O
interactions	O
of	O
circulating	B-cell_type
T	I-cell_type
cells	I-cell_type
with	O
endothelial	B-cell_type
cells	I-cell_type
.	O

Since	O
a	O
common	O
pathological	O
finding	O
in	O
human	O
T-cell	O
leukemia	O
virus	O
type	O
1	O
(	O
HTLV-1	O
)	O
-associated	O
diseases	O
is	O
the	O
infiltration	O
of	O
HTLV-1-infected	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
into	O
various	O
organs	O
,	O
we	O
have	O
looked	O
for	O
the	O
profile	O
of	O
adhesion	B-protein
molecules	I-protein
expressed	O
by	O
HTLV-1-transformed	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Flow	O
cytometry	O
analysis	O
indicated	O
that	O
these	O
cells	O
were	O
expressing	O
high	O
levels	O
of	O
vascular	B-protein
cell	I-protein
adhesion	I-protein
molecule	I-protein
1	I-protein
(	O
VCAM-1	B-protein
[	O
CD106	B-protein
]	O
)	O
,	O
a	O
110-kDa	O
member	O
of	O
the	O
immunoglobulin	B-protein
gene	I-protein
superfamily	I-protein
,	O
first	O
identified	O
on	O
endothelial	B-cell_type
cells	I-cell_type
stimulated	O
with	O
inflammatory	B-protein
cytokines	I-protein
.	O

This	O
adhesion	O
molecule	O
was	O
also	O
expressed	O
by	O
T	B-cell_type
cells	I-cell_type
obtained	O
from	O
one	O
patient	O
with	O
HTLV-1-associated	O
myelopathy/tropical	O
spastic	O
paraparesis	O
but	O
not	O
by	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
isolated	O
from	O
one	O
normal	O
blood	O
donor	O
.	O

The	O
role	O
of	O
the	O
viral	B-protein
trans-activator	I-protein
Tax	I-protein
protein	I-protein
in	O
the	O
induction	O
of	O
VCAM-1	B-protein
was	O
first	O
indicated	O
by	O
the	O
detection	O
of	O
this	O
adhesion	B-protein
molecule	I-protein
on	O
Jurkat	B-cell_line
T-cell	I-cell_line
clones	I-cell_line
stably	O
expressing	O
the	O
tax	O
gene	O
.	O

The	O
effect	O
of	O
Tax	B-protein
on	O
VCAM-1	B-protein
gene	O
transcription	O
was	O
next	O
confirmed	O
in	O
JPX-9	B-cell_line
cells	I-cell_line
,	O
a	O
subclone	O
of	O
Jurkat	B-cell_line
cells	I-cell_line
,	O
carrying	O
the	O
tax	B-DNA
sequences	I-DNA
under	O
the	O
control	O
of	O
an	O
inducible	B-DNA
promoter	I-DNA
.	O

Furthermore	O
,	O
deletion	O
and	O
mutation	O
analyses	O
of	O
the	O
VCAM-1	B-DNA
promoter	I-DNA
performed	O
with	O
chloramphenicol	B-DNA
acetyltransferase	I-DNA
constructs	I-DNA
revealed	O
that	O
Tax	B-protein
was	O
trans	O
activating	O
the	O
VCAM-1	B-DNA
promoter	I-DNA
via	O
two	O
NF-kappaB	B-DNA
sites	I-DNA
present	O
at	O
bp	O
-72	O
and	O
-57	O
in	O
the	O
VCAM-1	B-DNA
gene	I-DNA
promoter	I-DNA
,	O
with	O
both	O
of	O
them	O
being	O
required	O
for	O
the	O
Tax	B-protein
-induced	O
expression	O
of	O
this	O
adhesion	B-protein
molecule	I-protein
.	O

Finally	O
,	O
gel	O
mobility	O
shift	O
assays	O
demonstrated	O
the	O
nuclear	O
translocation	O
of	O
proteins	O
specifically	O
bound	O
to	O
these	O
two	O
NF-kappaB	B-DNA
motifs	I-DNA
,	O
confirming	O
that	O
VCAM-1	B-protein
was	O
induced	O
on	O
Tax-expressing	B-cell_line
cells	I-cell_line
in	O
a	O
kappaB	B-protein
-dependent	O
manner	O
.	O

Collectively	O
,	O
these	O
results	O
therefore	O
suggest	O
that	O
the	O
exclusive	O
Tax	B-protein
-induced	O
expression	O
of	O
VCAM-1	B-protein
on	O
T	B-cell_type
cells	I-cell_type
may	O
represent	O
a	O
pivotal	O
event	O
in	O
the	O
progression	O
of	O
HTLV-1-associated	O
diseases	O
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Nov.	NULL
1997	NULL
,	NULL
p.	NULL
8522-8530	NULL
0022-538X/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

71	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Transcriptional	NULL
Activation	NULL
of	NULL
the	NULL
Vascular	NULL
Cell	NULL
Adhesion	NULL
Molecule-1	NULL
Gene	NULL
in	NULL
T	NULL
Lymphocytes	NULL
Expressing	NULL
Human	NULL
T-Cell	NULL
Leukemia	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
Protein	NULL
HELENE	NULL
VALENTIN	NULL
,	NULL
ISABELLE	NULL
LEMASSON	NULL
,	NULL
``	NULL
SAMIR	NULL
HAMAIA	NULL
,	NULL
'	NULL
HUGUETTE	NULL
CASSE	NULL
,	NULL
!	NULL

STEPHANE	NULL
KONIG	NULL
,	NULL
CHRISTIAN	NULL
DEVAUX	NULL
,	NULL
``	NULL
anp	NULL
LOUIS	NULL
GAZZOLO'**	NULL
Immuno-Virologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
(	NULL
UMR	NULL
5537	NULL
)	NULL
,	NULL
CNRS-UCB	NULL
Lyon	NULL
I	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
Lyon-RTH	NULL
Laennec	NULL
,	NULL
69372	NULL
Lyon	NULL
Cedex	NULL
08	NULL
,	NULL
``	NULL
and	NULL
Laboratoire	NULL
d'Immunologie	NULL
des	NULL
Infections	NULL
Rétrovirales	NULL
,	NULL
CNRS	NULL
ERS	NULL
155-INSERM	NULL
U249	NULL
,	NULL
Institut	NULL
de	NULL
Biologie	NULL
,	NULL
34060	NULL
Montpellier	NULL
Cedex	NULL
,	NULL
``	NULL
France	NULL
.	NULL

Received	NULL
12	NULL
March	NULL
1997/Accepted	NULL
30	NULL
July	NULL
1997	NULL
Recruitment	NULL
and	NULL
extravasation	NULL
of	NULL
T	NULL
cells	NULL
through	NULL
the	NULL
blood-brain	NULL
barrier	NULL
are	NULL
favored	NULL
by	NULL
adhesion	NULL
molecule-mediated	NULL
interactions	NULL
of	NULL
circulating	NULL
T	NULL
cells	NULL
with	NULL
endothelial	NULL
cells	NULL
.	NULL

Since	NULL
a	NULL
common	NULL
pathological	NULL
finding	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
-associated	NULL
diseases	NULL
is	NULL
the	NULL
infiltration	NULL
of	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
into	NULL
various	NULL
organs	NULL
,	NULL
we	NULL
have	NULL
looked	NULL
for	NULL
the	NULL
profile	NULL
of	NULL
adhesion	NULL
molecules	NULL
expressed	NULL
by	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
indicated	NULL
that	NULL
these	NULL
cells	NULL
were	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
VCAM-1	NULL
[	NULL
CD106	NULL
]	NULL
)	NULL
,	NULL
a	NULL
110-kDa	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
superfamily	NULL
,	NULL
first	NULL
identified	NULL
on	NULL
endothelial	NULL
cells	NULL
stimulated	NULL
with	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

This	NULL
adhesion	NULL
molecule	NULL
was	NULL
also	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
obtained	NULL
from	NULL
one	NULL
patient	NULL
with	NULL
HTLV-1l-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
but	NULL
not	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
one	NULL
normal	NULL
blood	NULL
donor	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
viral	NULL
frans-activator	NULL
Tax	NULL
protein	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
was	NULL
first	NULL
indicated	NULL
by	NULL
the	NULL
detection	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
on	NULL
Jurkat	NULL
T-cell	NULL
clones	NULL
stably	NULL
expressing	NULL
the	NULL
tax	NULL
gene	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
VCAM-1	NULL
gene	NULL
transcription	NULL
was	NULL
next	NULL
confirmed	NULL
in	NULL
JPX-9	NULL
cells	NULL
,	NULL
a	NULL
subclone	NULL
of	NULL
Jurkat	NULL
cells	NULL
,	NULL
carrying	NULL
the	NULL
fax	NULL
sequences	NULL
under	NULL
the	NULL
control	NULL
of	NULL
an	NULL
inducible	NULL
promoter	NULL
.	NULL

Furthermore	NULL
,	NULL
deletion	NULL
and	NULL
mutation	NULL
analyses	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
performed	NULL
with	NULL
chloramphenicol	NULL
acetyltransferase	NULL
constructs	NULL
revealed	NULL
that	NULL
Tax	NULL
was	NULL
frans	NULL
activating	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
via	NULL
two	NULL
NF-B	NULL
sites	NULL
present	NULL
at	NULL
bp	NULL
-72	NULL
and	NULL
-57	NULL
in	NULL
the	NULL
VCAM-1	NULL
gene	NULL
promoter	NULL
,	NULL
with	NULL
both	NULL
of	NULL
them	NULL
being	NULL
required	NULL
for	NULL
the	NULL
Tax-induced	NULL
expression	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
.	NULL

Finally	NULL
,	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
demonstrated	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
proteins	NULL
specifically	NULL
bound	NULL
to	NULL
these	NULL
two	NULL
NF-KB	NULL
motifs	NULL
,	NULL
confirming	NULL
that	NULL
VCAM-1	NULL
was	NULL
induced	NULL
on	NULL
Tax-expressing	NULL
cells	NULL
in	NULL
a	NULL
«	NULL
B-dependent	NULL
manner	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
therefore	NULL
suggest	NULL
that	NULL
the	NULL
exclusive	NULL
Tax-induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
on	NULL
T	NULL
cells	NULL
may	NULL
represent	NULL
a	NULL
pivotal	NULL
event	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
HTLV-1l-associated	NULL
diseases	NULL
.	NULL

Most	NULL
of	NULL
individuals	NULL
infected	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
remain	NULL
asymptomatic	NULL
,	NULL
indicating	NULL
that	NULL
exposure	NULL
to	NULL
the	NULL
virus	NULL
leads	NULL
to	NULL
persistent	NULL
infection	NULL
that	NULL
rarely	NULL
results	NULL
in	NULL
disease	NULL
progression	NULL
.	NULL

Indeed	NULL
,	NULL
only	NULL
1	NULL
to	NULL
5	NULL
%	NULL
of	NULL
infected	NULL
persons	NULL
develop	NULL
either	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
(	NULL
ATL	NULL
)	NULL
or	NULL
a	NULL
nonmalignant	NULL
neurologic	NULL
disorder	NULL
termed	NULL
HTLV-l-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
paraparesis	NULL
(	NULL
HAM/TSP	NULL
)	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
39	NULL
,	NULL
41	NULL
,	NULL
50	NULL
,	NULL
54	NULL
,	NULL
56	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
involved	NULL
in	NULL
progression	NULL
to	NULL
either	NULL
disease	NULL
remain	NULL
to	NULL
be	NULL
clarified	NULL
,	NULL
but	NULL
might	NULL
include	NULL
genetic	NULL
predisposition	NULL
,	NULL
age	NULL
at	NULL
infection	NULL
,	NULL
routes	NULL
of	NULL
transmission	NULL
,	NULL
and	NULL
differences	NULL
of	NULL
the	NULL
host	NULL
immune	NULL
responses	NULL
.	NULL

The	NULL
interplay	NULL
of	NULL
two	NULL
viral	NULL
regulatory	NULL
proteins	NULL
,	NULL
Tax	NULL
and	NULL
Rex	NULL
,	NULL
strictly	NULL
regulates	NULL
HTLV-1	NULL
gene	NULL
expression	NULL
.	NULL

Tax	NULL
,	NULL
a	NULL
40-kDa	NULL
nuclear	NULL
protein	NULL
,	NULL
increases	NULL
transcription	NULL
by	NULL
acting	NULL
via	NULL
21-bp	NULL
repeats	NULL
found	NULL
in	NULL
the	NULL
proviral	NULL
5	NULL
'	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
.	NULL

Rex	NULL
,	NULL
a	NULL
27-kDa	NULL
nuclear/nucleolar	NULL
protein	NULL
,	NULL
acts	NULL
at	NULL
the	NULL
posttranscrip-tional	NULL
level	NULL
via	NULL
an	NULL
mRNA	NULL
Rex-responsive	NULL
element	NULL
located	NULL
in	NULL
the	NULL
3	NULL
'	NULL
LTR	NULL
to	NULL
facilitate	NULL
the	NULL
export	NULL
of	NULL
mRNAs	NULL
required	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
viral	NULL
enzymes	NULL
and	NULL
structural	NULL
proteins	NULL
(	NULL
7	NULL
,	NULL
10	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
numerous	NULL
investigations	NULL
have	NULL
been	NULL
devoted	NULL
to	NULL
unraveling	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
onset	NULL
and	NULL
development	NULL
of	NULL
dis	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Immuno-Virologie	NULL
Moléculaire	NULL
et	NULL
Cellulaire	NULL
(	NULL
UMR5537	NULL
)	NULL
,	NULL
CNRS-UCB	NULL
Lyon	NULL
I	NULL
,	NULL
Faculté	NULL
de	NULL
Médecine	NULL
Lyon-RTH	NULL
Lagnnec	NULL
,	NULL
Rue	NULL
Guillaume	NULL
Paradin	NULL
,	NULL
69372	NULL
Lyon	NULL
Cedex	NULL
08	NULL
,	NULL
France	NULL
.	NULL

Phone	NULL
:	NULL
33	NULL
4	NULL
78	NULL
77	NULL
86	NULL
17	NULL
.	NULL

Fax	NULL
:	NULL
33	NULL
4	NULL
78	NULL
77	NULL
87	NULL
51	NULL
.	NULL

E-mail	NULL
:	NULL
gazzolo	NULL
@	NULL
cimacpcu.univ-lyon1.fr	NULL
.	NULL

8522	NULL
eases	NULL
linked	NULL
to	NULL
HTLV-1	NULL
T-cell	NULL
infection	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
trans-activating	NULL
capacity	NULL
of	NULL
Tax	NULL
enables	NULL
this	NULL
protein	NULL
to	NULL
intervene	NULL
in	NULL
the	NULL
induction	NULL
and/or	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
a	NULL
large	NULL
collection	NULL
of	NULL
cellular	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
those	NULL
coding	NULL
for	NULL
cytokines	NULL
,	NULL
cytokine	NULL
receptors	NULL
,	NULL
proto-oncogenes	NULL
,	NULL
and	NULL
cytoskeletal	NULL
proteins	NULL
such	NULL
as	NULL
vimentin	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Tax	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
directly	NULL
(	NULL
2	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
cellular	NULL
genes	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
Tax	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
activating	NULL
transcription	NULL
factor/cyclic	NULL
AMP-responsive	NULL
element-binding	NULL
(	NULL
ATF-1/CREB	NULL
)	NULL
family	NULL
and	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
4	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
by	NULL
interacting	NULL
with	NULL
IxBa	NULL
or	NULL
NF-kB	NULL
precursors	NULL
,	NULL
Tax	NULL
is	NULL
able	NULL
to	NULL
increase	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-related	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
3	NULL
,	NULL
17	NULL
,	NULL
34	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
by	NULL
deregulating	NULL
the	NULL
transcription	NULL
of	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
proliferation	NULL
,	NULL
Tax	NULL
is	NULL
playing	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
viral	NULL
pathogenesis	NULL
.	NULL

A	NULL
pathological	NULL
finding	NULL
common	NULL
to	NULL
ATL	NULL
and	NULL
HAM/TSP	NULL
is	NULL
the	NULL
infiltration	NULL
of	NULL
lymphocytes	NULL
into	NULL
various	NULL
organs	NULL
.	NULL

Indeed	NULL
,	NULL
ATL	NULL
cells	NULL
are	NULL
able	NULL
to	NULL
invade	NULL
organs	NULL
such	NULL
as	NULL
the	NULL
liver	NULL
,	NULL
spleen	NULL
,	NULL
lungs	NULL
,	NULL
and	NULL
skin	NULL
(	NULL
50	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
infiltration	NULL
of	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
into	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
may	NULL
be	NULL
a	NULL
hallmark	NULL
of	NULL
the	NULL
evolution	NULL
of	NULL
the	NULL
pathogenic	NULL
process	NULL
and	NULL
may	NULL
act	NULL
by	NULL
triggering	NULL
the	NULL
chronic	NULL
inflammatory	NULL
lesions	NULL
observed	NULL
in	NULL
HAM/TSP	NULL
patients	NULL
(	NULL
18	NULL
,	NULL
20-22	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
emigration	NULL
of	NULL
lymphocytes	NULL
from	NULL
the	NULL
periphery	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
three	NULL
distinct	NULL
interactions	NULL
of	NULL
adhesion	NULL
molecules	NULL
with	NULL
endothelial	NULL
cells	NULL
,	NULL
selectin-carbohydrate	NULL
,	NULL
chemoattractant-receptor	NULL
,	NULL
and	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
integrin-immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
5	NULL
and	NULL
48	NULL
)	NULL
.	NULL

Recent	NULL
observations	NULL
have	NULL
provided	NULL
evidence	NULL
for	NULL
the	NULL
Tax-induced	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
which	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
HTLV-1-infected	NULL
T-cell	NULL
infiltration	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
has	NULL
been	NULL
observed	NULL
that	NULL
Tax	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
upregulation	NULL
of	NULL
both	NULL
intercellular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
ICAM-1	NULL
[	NULL
CDS54	NULL
]	NULL
)	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
superfamily	NULL
,	NULL
and	NULL
lymphocyte	NULL
function	NULL
antigen	NULL
3	NULL
(	NULL
LFA-3	NULL
[	NULL
CD58	NULL
]	NULL
)	NULL
in	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
(	NULL
32	NULL
,	NULL
51	NULL
,	NULL
52	NULL
)	NULL
.	NULL

The	NULL
L-selectin	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
constitutively	NULL
overexpressed	NULL
in	NULL
fresh	NULL
ATL	NULL
cells	NULL
,	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
Tax	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Besides	NULL
these	NULL
conventional	NULL
adhesion	NULL
models	NULL
,	NULL
the	NULL
OX40/gp34	NULL
interactions	NULL
define	NULL
another	NULL
adhesion	NULL
pathway	NULL
.	NULL

Indeed	NULL
,	NULL
OX40	NULL
,	NULL
a	NULL
type	NULL
I	NULL
transmembrane	NULL
protein	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
family	NULL
expressed	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
mediates	NULL
the	NULL
adhesion	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
gp34	NULL
(	NULL
OX4A40L	NULL
)	NULL
,	NULL
present	NULL
on	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

Both	NULL
OX40	NULL
and	NULL
gp34	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
constitutively	NULL
expressed	NULL
on	NULL
the	NULL
membrane	NULL
of	NULL
Tax-expressing	NULL
T	NULL
lymphocytes	NULL
(	NULL
15	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
first	NULL
show	NULL
that	NULL
T	NULL
cells	NULL
carrying	NULL
proviral	NULL
HTLV-1	NULL
were	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
VCAM-1-CD106	NULL
)	NULL
,	NULL
a	NULL
110-kDa	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
superfamily	NULL
,	NULL
which	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
mainly	NULL
on	NULL
endothelial	NULL
cells	NULL
,	NULL
only	NULL
when	NULL
stimulated	NULL
with	NULL
inflammatory	NULL
mediators	NULL
(	NULL
9	NULL
,	NULL
40	NULL
)	NULL
.	NULL

We	NULL
then	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
Tax	NULL
in	NULL
trans-activating	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
by	NULL
Jurkat	NULL
clones	NULL
stably	NULL
expressing	NULL
the	NULL
tex	NULL
gene	NULL
and	NULL
finally	NULL
determine	NULL
the	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
that	NULL
were	NULL
responsive	NULL
to	NULL
Tax	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
present	NULL
at	NULL
positions	NULL
-72	NULL
and	NULL
-53	NULL
in	NULL
the	NULL
VCAM-1	NULL
gene	NULL
promoter	NULL
are	NULL
absolutely	NULL
required	NULL
for	NULL
the	NULL
Tax-induced	NULL
expression	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
.	NULL

The	NULL
mouse	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MAbs	NULL
)	NULL
directed	NULL
against	NULL
human	NULL
VCAM-1-CD106	NULL
were	NULL
clones	NULL
1G11	NULL
and	NULL
1.4C3	NULL
from	NULL
Immunotech	NULL
,	NULL
Mar-seilles	NULL
,	NULL
France	NULL
,	NULL
and	NULL
from	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
,	NULL
respectively	NULL
.	NULL

Mouse	NULL
MAbs	NULL
to	NULL
CD25	NULL
(	NULL
clone	NULL
B1.49.9	NULL
)	NULL
and	NULL
CD80	NULL
(	NULL
clone	NULL
104	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Immuno-tech	NULL
.	NULL

IgG1	NULL
,	NULL
IgG2a	NULL
(	NULL
Dako	NULL
)	NULL
,	NULL
and	NULL
IgG2b	NULL
(	NULL
Immunotech	NULL
)	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
.	NULL

The	NULL
rabbit	NULL
anti-Tax	NULL
antiserum	NULL
directed	NULL
against	NULL
a	NULL
specific	NULL
synthetic	NULL
peptide	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
B.	NULL
R.	NULL
Cullen	NULL
(	NULL
Howard	NULL
Hughes	NULL
Institute	NULL
,	NULL
Durham	NULL
,	NULL
N.C.	NULL
)	NULL
.	NULL

Rabbit	NULL
anti-actin	NULL
antiserum	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

.	NULL

Cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco	NULL
Laboratories	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
N.Y.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Dutscher	NULL
,	NULL
Bru-math	NULL
,	NULL
France	NULL
)	NULL
,	NULL
5	NULL
mM	NULL
r-glutamine	NULL
,	NULL
and	NULL
50	NULL
pg	NULL
of	NULL
gentamicin	NULL
per	NULL
ml	NULL
(	NULL
both	NULL
from	NULL
Gibco	NULL
)	NULL
.	NULL

We	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
i	NULL
)	NULL
two	NULL
HTLV-1-negative	NULL
T-cell	NULL
lines	NULL
(	NULL
Jurkat	NULL
and	NULL
CEM	NULL
)	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
two	NULL
HTLV-1-transformed	NULL
T-cell	NULL
lines	NULL
(	NULL
MT2	NULL
[	NULL
31	NULL
]	NULL
and	NULL
C8166	NULL
[	NULL
44	NULL
]	NULL
)	NULL
;	NULL
(	NULL
iii	NULL
)	NULL
three	NULL
clones	NULL
of	NULL
Jurkat	NULL
cells	NULL
stably	NULL
expressing	NULL
Tax	NULL
(	NULL
28	NULL
)	NULL
(	NULL
clones	NULL
C11	NULL
and	NULL
E12	NULL
,	NULL
which	NULL
were	NULL
obtained	NULL
after	NULL
cotransfection	NULL
with	NULL
pMTenvXLTR	NULL
together	NULL
with	NULL
the	NULL
SV40-Neo	NULL
plasmid	NULL
,	NULL
and	NULL
clone	NULL
50	NULL
,	NULL
which	NULL
was	NULL
obtained	NULL
after	NULL
cotransfection	NULL
with	NULL
plasmid	NULL
pMTtax	NULL
and	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
neo	NULL
resistance	NULL
gene	NULL
;	NULL
Tax	NULL
expressed	NULL
by	NULL
the	NULL
C11	NULL
,	NULL
E12	NULL
,	NULL
and	NULL
50	NULL
Jurkat	NULL
clones	NULL
was	NULL
found	NULL
to	NULL
be	NULL
functional	NULL
for	NULL
the	NULL
trans-activation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
[	NULL
28	NULL
]	NULL
)	NULL
;	NULL
(	NULL
iv	NULL
)	NULL
the	NULL
JPX-9	NULL
cell	NULL
line	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
K.	NULL
Sugamura	NULL
,	NULL
Tohoku	NULL
University	NULL
,	NULL
Sendai	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
which	NULL
was	NULL
generated	NULL
by	NULL
the	NULL
stable	NULL
introduction	NULL
of	NULL
a	NULL
Tax	NULL
expression	NULL
plasmid	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
human	NULL
metallothionein	NULL
promoter	NULL
(	NULL
induction	NULL
of	NULL
Tax	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Cd**	NULL
or	NULL
Zn	NULL
``	NULL
*	NULL
[	NULL
35	NULL
]	NULL
)	NULL
;	NULL
and	NULL
(	NULL
v	NULL
)	NULL
the	NULL
Tax-negative	NULL
Jurkat	NULL
C9	NULL
clone	NULL
,	NULL
which	NULL
was	NULL
obtained	NULL
from	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
neo	NULL
resistance	NULL
gene	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Freshly	NULL
isolated	NULL
T	NULL
cells	NULL
from	NULL
one	NULL
HAM/TSP	NULL
patient	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
C.	NULL
Blanc-Desgranges	NULL
(	NULL
INSERM	NULL
U271	NULL
,	NULL
Lyon	NULL
,	NULL
France	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
T	NULL
cells	NULL
isolated	NULL
from	NULL
one	NULL
normal	NULL
blood	NULL
donor	NULL
and	NULL
activated	NULL
with	NULL
phytohemagglutinin	NULL
were	NULL
then	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
10	NULL
U	NULL
of	NULL
recombinant	NULL
human	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
per	NULL
ml	NULL
(	NULL
Boehringer	NULL
,	NULL
Mann-heim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
and	NULL
reagents	NULL
.	NULL

The	NULL
cellular	NULL
oligonucleotide	NULL
primers	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
VCAM-3	NULL
(	NULL
5'-CCAGA	NULL
GATAC	NULL
AACCG	NULL
TCTTG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
2903	NULL
to	NULL
2922	NULL
,	NULL
sense	NULL
)	NULL
,	NULL
VCAM-4	NULL
(	NULL
5-GAGCA	NULL
CGAGA	NULL
AGCTC	NULL
AGGAG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
3968	NULL
to	NULL
3987	NULL
,	NULL
antisense	NULL
)	NULL
,	NULL
TKI	NULL
(	NULL
5-GAGTA	NULL
CTCGG	NULL
GTTCG	NULL
TGAAC-3	NULL
'	NULL
,	NULL
nucleotides	NULL
24	NULL
to	NULL
43	NULL
,	NULL
sense	NULL
)	NULL
,	NULL
and	NULL
TKI	NULL
(	NULL
5-GGTCA	NULL
TGTGT	NULL
GCAGA	NULL
AGCTG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
246	NULL
to	NULL
265	NULL
,	NULL
antisense	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
nucleotide	NULL
primers	NULL
were	NULL
TRU	NULL
2	NULL
(	NULL
5'-TGTTT	NULL
GGAGA	NULL
CTGTG	NULL
TACAA	NULL
GGCG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
7353	NULL
to	NULL
7376	NULL
,	NULL
sense	NULL
)	NULL
and	NULL
Tax	NULL
2	NULL
(	NULL
5'-CAGGC	NULL
TGTTA	NULL
GCGTG	NULL
ACGG-3	NULL
'	NULL
,	NULL
nucleotides	NULL
7968	NULL
to	NULL
7986	NULL
,	NULL
antisense	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
purchased	NULL
from	NULL
Tax-INDUCED	NULL
VCAM-1	NULL
EXPRESSION	NULL
BY	NULL
T	NULL
CELLS	NULL
-	NULL
8523	NULL
Eurogentec	NULL
(	NULL
Seraing	NULL
,	NULL
Belgium	NULL
)	NULL
.	NULL

Pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
was	NULL
from	NULL
Sigma	NULL
.	NULL

Plasmids	NULL
and	NULL
transfections	NULL
.	NULL

pMTenvyXLTR	NULL
,	NULL
containing	NULL
the	NULL
coding	NULL
sequences	NULL
of	NULL
env	NULL
,	NULL
fax	NULL
,	NULL
and	NULL
rex	NULL
together	NULL
with	NULL
the	NULL
HTLV-1	NULL
3	NULL
'	NULL
LTR	NULL
,	NULL
and	NULL
MT-Tax	NULL
,	NULL
encoding	NULL
only	NULL
Tax	NULL
,	NULL
were	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
mouse	NULL
metallothionein	NULL
promoter	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Another	NULL
Tax	NULL
expression	NULL
plasmid	NULL
(	NULL
SV40-Tax	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Jalinot	NULL
(	NULL
Ecole	NULL
Normale	NULL
Supérieure	NULL
,	NULL
Lyon	NULL
)	NULL
.	NULL

The	NULL
SV40-Neo	NULL
plasmid	NULL
carries	NULL
the	NULL
neo	NULL
resistance	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
(	NULL
SV40	NULL
)	NULL
promoter	NULL
.	NULL

Three	NULL
VCAM-1	NULL
reporter	NULL
plasmids	NULL
in	NULL
which	NULL
various	NULL
fragments	NULL
of	NULL
the	NULL
promoter/en-hancer	NULL
region	NULL
of	NULL
the	NULL
human	NULL
VCAM-1	NULL
gene	NULL
were	NULL
linked	NULL
to	NULL
bacterial	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
36	NULL
)	NULL
and	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
T.	NULL
Collins	NULL
(	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

.	NULL

These	NULL
deletion	NULL
plasmids	NULL
were	NULL
FfL-pCAT3	NULL
(	NULL
-2167	NULL
)	NULL
,	NULL
F3-pCAT3	NULL
(	NULL
-98	NULL
)	NULL
,	NULL
and	NULL
F4-pCAT	NULL
(	NULL
-44	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
two	NULL
F3MA-pCAT3	NULL
and	NULL
F3MB-pCAT3	NULL
constructs	NULL
,	NULL
both	NULL
derived	NULL
from	NULL
the	NULL
F3-pCAT3	NULL
plasmid	NULL
,	NULL
have	NULL
point	NULL
mutations	NULL
in	NULL
the	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
NF-	NULL
«	NULL
B	NULL
motifs	NULL
,	NULL
respectively	NULL
.	NULL

Transfections	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
electroporation	NULL
at	NULL
250	NULL
V	NULL
and	NULL
1,500	NULL
F	NULL
with	NULL
the	NULL
Celljet	NULL
electroporator	NULL
(	NULL
Eurogentec	NULL
)	NULL
.	NULL

CAT	NULL
assay	NULL
.	NULL

CEM	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
LTRgrriv1y	NULL
CAT	NULL
,	NULL
Ffi-pCAT3	NULL
(	NULL
-2167	NULL
)	NULL
,	NULL
F3pCAT3	NULL
(	NULL
-98	NULL
)	NULL
,	NULL
or	NULL
F4-pCAT3	NULL
(	NULL
-44	NULL
)	NULL
construct	NULL
(	NULL
20	NULL
g	NULL
)	NULL
or	NULL
cotransfected	NULL
with	NULL
the	NULL
same	NULL
plasmids	NULL
and	NULL
the	NULL
SV40-Tax	NULL
construct	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
by	NULL
a	NULL
previously	NULL
published	NULL
procedure	NULL
(	NULL
27	NULL
)	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
48	NULL
h	NULL
and	NULL
then	NULL
harvested	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
300	NULL
x	NULL
g	NULL
for	NULL
3	NULL
min	NULL
,	NULL
the	NULL
cell	NULL
pellets	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
disintegrated	NULL
by	NULL
four	NULL
rounds	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
aliquots	NULL
of	NULL
the	NULL
clear	NULL
supernatant	NULL
were	NULL
tested	NULL
for	NULL
the	NULL
CAT	NULL
protein	NULL
by	NULL
a	NULL
CAT	NULL
antigen	NULL
capture	NULL
assay	NULL
(	NULL
Boehringer	NULL
)	NULL
.	NULL

An	NULL
internal	NULL
control	NULL
was	NULL
made	NULL
available	NULL
with	NULL
the	NULL
kit	NULL
that	NULL
allows	NULL
quantification	NULL
of	NULL
the	NULL
CAT	NULL
enzyme	NULL
contained	NULL
in	NULL
the	NULL
extracts	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
JPX-9	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
LTR	NULL
(	NULL
gyry-y-CAT	NULL
,	NULL
F	NULL
{	NULL
I-pCAT3	NULL
(	NULL
-2167	NULL
)	NULL
,	NULL
F3pCAT3	NULL
(	NULL
-98	NULL
)	NULL
,	NULL
or	NULL
F4-pCAT3	NULL
(	NULL
-44	NULL
)	NULL
construct	NULL
(	NULL
20	NULL
pg	NULL
)	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
cadmium	NULL
and	NULL
the	NULL
CAT	NULL
assay	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
published	NULL
method	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
method	NULL
uses	NULL
[	NULL
»	NULL
HJacetyl	NULL
coenzyme	NULL
as	NULL
the	NULL
acetyl	NULL
donor	NULL
,	NULL
and	NULL
relies	NULL
on	NULL
the	NULL
diffusion	NULL
of	NULL
labelled	NULL
acetylchloramphenicol	NULL
into	NULL
a	NULL
water-immiscible	NULL
liquid	NULL
scintillation	NULL
cock-tail	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
[	NULL
*HJacetylchloramphenicol	NULL
produced	NULL
was	NULL
measured	NULL
directly	NULL
by	NULL
counting	NULL
the	NULL
samples	NULL
at	NULL
selected	NULL
time	NULL
intervals	NULL
.	NULL

RT-PCR	NULL
assay	NULL
.	NULL

PCR	NULL
detection	NULL
of	NULL
retrotranscribed	NULL
RNAs	NULL
was	NULL
performed	NULL
by	NULL
a	NULL
previously	NULL
published	NULL
procedure	NULL
with	NULL
slight	NULL
modifications	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
in	NULL
guanidinium	NULL
thiocyanate	NULL
from	NULL
4	NULL
%	NULL
10°	NULL
cells	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
of	NULL
H	NULL
,	NULL
O0-0.1	NULL
%	NULL
diethylpyrocarbonate	NULL
.	NULL

To	NULL
reduce	NULL
the	NULL
amount	NULL
of	NULL
DNA	NULL
originating	NULL
from	NULL
lysis	NULL
,	NULL
supernatants	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
U	NULL
of	NULL
RNase-free	NULL
DNase	NULL
(	NULL
Boehringer	NULL
)	NULL
per	NULL
pl	NULL
for	NULL
30	NULL
min	NULL
at	NULL
20°C	NULL
and	NULL
then	NULL
for	NULL
5	NULL
min	NULL
at	NULL
65°C	NULL
.	NULL

To	NULL
2	NULL
ug	NULL
of	NULL
RNA	NULL
sample	NULL
(	NULL
10	NULL
pl	NULL
)	NULL
was	NULL
added	NULL
200	NULL
ng	NULL
of	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primer	NULL
(	NULL
1	NULL
wl	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
65°C	NULL
.	NULL

Each	NULL
sample	NULL
was	NULL
made	NULL
up	NULL
with	NULL
reaction	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
,	NULL
30	NULL
mM	NULL
KCI	NULL
,	NULL
8	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
9	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
DTT	NULL
)	NULL
,	NULL
320	NULL
nM	NULL
deoxynucleoside	NULL
triphosphate	NULL
)	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
25	NULL
pl	NULL
,	NULL
supplemented	NULL
with	NULL
20	NULL
U	NULL
of	NULL
RNase	NULL
inhibitor	NULL
(	NULL
Boehringer	NULL
)	NULL
and	NULL
25	NULL
U	NULL
of	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
(	NULL
AMV	NULL
)	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Boehringer	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
at	NULL
42°C	NULL
.	NULL

PCRs	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
4	NULL
pul	NULL
of	NULL
the	NULL
sample	NULL
supplemented	NULL
with	NULL
an	NULL
amplification	NULL
mixture	NULL
containing	NULL
20	NULL
pmol	NULL
of	NULL
each	NULL
of	NULL
the	NULL
oligonucleotide	NULL
primers	NULL
and	NULL
2	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
.	NULL

The	NULL
amplification	NULL
reaction	NULL
was	NULL
run	NULL
in	NULL
a	NULL
PHC2	NULL
thermal	NULL
cycler	NULL
(	NULL
Techne	NULL
,	NULL
Cam-bridge	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
products	NULL
were	NULL
electrophoresed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
y-*°P-labeled	NULL
probe	NULL
.	NULL

Labeled	NULL
DNA	NULL
products	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
suspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
PBS	NULL
containing	NULL
a	NULL
saturating	NULL
amount	NULL
of	NULL
unconjugated	NULL
MAb	NULL
and	NULL
5	NULL
%	NULL
goat	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
and	NULL
then	NULL
incubated	NULL
in	NULL
ice	NULL
for	NULL
45	NULL
min	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
ice	NULL
with	NULL
a	NULL
1:50	NULL
dilution	NULL
of	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
Dako	NULL
)	NULL
in	NULL
PBS	NULL
with	NULL
5	NULL
%	NULL
goat	NULL
serum	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
three	NULL
washes	NULL
in	NULL
PBS	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
.	NULL

A	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
Calif.	NULL
)	NULL
FACScan	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
fluorescence-labeled	NULL
cells	NULL
.	NULL

Integrated	NULL
fluorescence	NULL
of	NULL
the	NULL
gated	NULL
population	NULL
was	NULL
measured	NULL
,	NULL
and	NULL
data	NULL
were	NULL
collected	NULL
from	NULL
at	NULL
least	NULL
10,000	NULL
events	NULL
.	NULL

For	NULL
analysis	NULL
following	NULL
PDTC	NULL
treatment	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
propidium	NULL
iodide	NULL
(	NULL
Sigma	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
by	NULL
the	NULL
DNA-labeling	NULL
technique	NULL
.	NULL

Dead	NULL
cells	NULL
labeled	NULL
with	NULL
propidium	NULL
iodide	NULL
were	NULL
excluded	NULL
from	NULL
the	NULL
analysis	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
harvested	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
a	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
sample	NULL
buffer	NULL
,	NULL
scraped	NULL
,	NULL
and	NULL
then	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
lysates	NULL
(	NULL
30	NULL
ug	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
on	NULL
SDS-7.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

The	NULL
fractionated	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
membranes	NULL
(	NULL
BA	NULL
85	NULL
;	NULL
Schleicher	NULL
&	NULL
Schiill	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
with	NULL
a	NULL
semidry-blotting	NULL
device	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
blocked	NULL
with	NULL
a	NULL
10	NULL
%	NULL
nonfat	NULL
millk-0.1	NULL
%	NULL
Tween	NULL
20-PBS	NULL
solution	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
probed	NULL
with	NULL
the	NULL
appropriate	NULL
antibody	NULL
for	NULL
1	NULL
h.	NULL
They	NULL
were	NULL
then	NULL
rinsed	NULL
with	NULL
PBS-0.1	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
a	NULL
secondary	NULL
horseradish	NULL
peroxidase-conjugated	NULL
anti-mouse	NULL
antibody	NULL
for	NULL
1	NULL
h.	NULL
Following	NULL
four	NULL
additional	NULL
rinses	NULL
in	NULL
PBS-0.1	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
blots	NULL
were	NULL
developed	NULL
by	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
Luminol	NULL
reagent	NULL
[	NULL
CovalAb	NULL
,	NULL
Oullins	NULL
,	NULL
France	NULL
]	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
subjected	NULL
to	NULL
autoradiography	NULL
with	NULL
Hyperfilm	NULL
MP	NULL
(	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
111	NULL
)	NULL
.	NULL

8524	NULL
VALENTIN	NULL
ET	NULL
AL	NULL
.	NULL

$	NULL
MT2	NULL
Relative	NULL
Cell	NULL
Number	NULL
Fluorescence	NULL
Intensity	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
VCAM-1	NULL
expression	NULL
by	NULL
in	NULL
vitro	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
.	NULL

C8166	NULL
and	NULL
MT2	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
a	NULL
MAb	NULL
to	NULL
VCAM-1	NULL
(	NULL
1G11	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
FITC-conjugated	NULL
anti-mouse	NULL
Ig	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Fluorescence	NULL
profiles	NULL
are	NULL
shown	NULL
as	NULL
dark	NULL
histograms	NULL
after	NULL
labeling	NULL
with	NULL
the	NULL
VCAM-1	NULL
MAb	NULL
and	NULL
as	NULL
light	NULL
histograms	NULL
after	NULL
labeling	NULL
with	NULL
an	NULL
IgG1	NULL
isotype	NULL
control	NULL
MAb	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
3	NULL
to	NULL
10	NULL
separate	NULL
experiments	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
a	NULL
published	NULL
method	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
harvested	NULL
after	NULL
a	NULL
16-h	NULL
incubation	NULL
at	NULL
37°C	NULL
in	NULL
culture	NULL
medium	NULL
(	NULL
or	NULL
medium	NULL
supplemented	NULL
with	NULL
additives	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
;	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
transferred	NULL
into	NULL
1.5-ml	NULL
Eppendorf	NULL
tubes	NULL
,	NULL
and	NULL
microcentrifuged	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
s.	NULL
The	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
800	NULL
pl	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
2	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
)	NULL
.	NULL

After	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
a	NULL
50-pl	NULL
solution	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
was	NULL
added	NULL
to	NULL
the	NULL
sample	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
homogenized	NULL
by	NULL
vortexing	NULL
and	NULL
microcentrifuged	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
s.	NULL
The	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
100	NULL
l	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
300	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
0.1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
microcentrifuged	NULL
at	NULL
4°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
used	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extract	NULL
,	NULL
10°	NULL
cpm	NULL
of	NULL
radiolabeled	NULL
double-stranded	NULL
probe	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
NF-kB	NULL
sense	NULL
strand	NULL
only	NULL
:	NULL
CCTC-3	NULL
'	NULL
)	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
ZnSO	NULL
,	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.01	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
,	NULL
supplemented	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
tRNA	NULL
,	NULL
and	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
20	NULL
pI	NULL
.	NULL

After	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
run	NULL
at	NULL
120	NULL
V	NULL
in	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
10-	NULL
,	NULL
50-	NULL
,	NULL
and	NULL
100-fold	NULL
molar	NULL
excesses	NULL
of	NULL
the	NULL
same	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
double-stranded	NULL
oligonucleotide	NULL
sequence	NULL
or	NULL
unrelated	NULL
Sp-1	NULL
oligonucleotide	NULL
(	NULL
Sp-1	NULL
sense	NULL
strand	NULL
only	NULL
:	NULL
5-GGA	NULL
GGCGTGGCCTGGGCGGGACTGGGGAGTGGCGA-	NULL
»	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
VCAM-1	NULL
by	NULL
HTLV-1-infected	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
by	NULL
Jurkat	NULL
clones	NULL
stably	NULL
transformed	NULL
with	NULL
Tax	NULL
expression	NULL
plasmids	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
adhesion	NULL
molecules	NULL
by	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
(	NULL
C8166	NULL
and	NULL
MT2	NULL
)	NULL
allowed	NULL
us	NULL
to	NULL
show	NULL
that	NULL
these	NULL
cells	NULL
are	NULL
expressing	NULL
VCAM-1	NULL
,	NULL
as	NULL
ascertained	NULL
either	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
MAb	NULL
1G11	NULL
or	NULL
1.4C3	NULL
to	NULL
CD106	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
or	NULL
by	NULL
immunofluorescence	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
from	NULL
one	NULL
HAM/TSP	NULL
patient	NULL
were	NULL
found	NULL
to	NULL
express	NULL
VCAM-1	NULL
together	NULL
with	NULL
CD25	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
VCAM-1	NULL
was	NULL
not	NULL
detected	NULL
on	NULL
T	NULL
cells	NULL
derived	NULL
from	NULL
one	NULL
normal	NULL
(	NULL
HTLV-1-seronegative	NULL
)	NULL
blood	NULL
donor	NULL
,	NULL
even	NULL
when	NULL
they	NULL
were	NULL
activated	NULL
with	NULL
phytohemagglutinin	NULL
and	NULL
cultivated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
these	NULL
cells	NULL
were	NULL
expressing	NULL
CD25	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Since	NULL
Tax	NULL
is	NULL
the	NULL
only	NULL
viral	NULL
protein	NULL
expressed	NULL
by	NULL
C8166	NULL
cells	NULL
and	NULL
it	NULL
is	NULL
expressed	NULL
by	NULL
T	NULL
cells	NULL
from	NULL
HAM/TSP	NULL
patients	NULL
,	NULL
the	NULL
role	NULL
played	NULL
by	NULL
this	NULL
viral	NULL
regulatory	NULL
protein	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
was	NULL
next	NULL
investigated	NULL
by	NULL
using	NULL
Jurkat	NULL
T	NULL
cells	NULL
that	NULL
stably	NULL
express	NULL
Tax	NULL
.	NULL

Three	NULL
clones	NULL
of	NULL
Jurkat	NULL
cells	NULL
,	NULL
clones	NULL
C11	NULL
and	NULL
E12	NULL
,	NULL
which	NULL
express	NULL
both	NULL
Tax	NULL
and	NULL
Rex	NULL
,	NULL
and	NULL
clone	NULL
50	NULL
,	NULL
which	NULL
expresses	NULL
only	NULL
Tax	NULL
,	NULL
were	NULL
found	NULL
to	NULL
express	NULL
VCAM-1	NULL
at	NULL
a	NULL
level	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
J.	NULL
Viror	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Parental	NULL
Jurkat	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
cells	NULL
from	NULL
a	NULL
Tax-negative	NULL
Jurkat	NULL
clone	NULL
,	NULL
C9	NULL
(	NULL
obtained	NULL
under	NULL
the	NULL
same	NULL
selection	NULL
procedure	NULL
as	NULL
the	NULL
Tax-positive	NULL
clones	NULL
)	NULL
,	NULL
did	NULL
not	NULL
express	NULL
VCAM-1	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
performed	NULL
under	NULL
nonreducing	NULL
conditions	NULL
with	NULL
a	NULL
blotting	NULL
MAb	NULL
directed	NULL
against	NULL
VCAM-1	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
protein	NULL
of	NULL
approximately	NULL
97	NULL
kDa	NULL
in	NULL
extracts	NULL
of	NULL
Tax-positive	NULL
C11	NULL
,	NULL
E12	NULL
,	NULL
50	NULL
,	NULL
and	NULL
C8166	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
weight	NULL
of	NULL
this	NULL
protein	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
seven	NULL
Ig-like	NULL
domains	NULL
of	NULL
the	NULL
VCAM-1	NULL
molecule	NULL
.	NULL

No	NULL
such	NULL
protein	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
extracts	NULL
of	NULL
parental	NULL
Jurkat	NULL
and	NULL
C9	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
suggest	NULL
that	NULL
Tax	NULL
expression	NULL
in	NULL
Jurkat	NULL
cells	NULL
correlates	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

VCAM-1	NULL
expression	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
Tax	NULL
concentration	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
further	NULL
evaluate	NULL
the	NULL
effect	NULL
of	NULL
Tax	NULL
on	NULL
VCAM-1	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
next	NULL
used	NULL
JPX-9	NULL
cells	NULL
,	NULL
a	NULL
subclone	NULL
of	NULL
Jurkat	NULL
cells	NULL
that	NULL
was	NULL
stably	NULL
transformed	NULL
with	NULL
the	NULL
pMAXRHneo-1	NULL
plasmid	NULL
carrying	NULL
the	NULL
fax	NULL
sequences	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
human	NULL
metallothionein	NULL
promoter	NULL
responsive	NULL
to	NULL
heavy-metal	NULL
ions	NULL
.	NULL

Previous	NULL
experiments	NULL
performed	NULL
with	NULL
JPX-9	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
LTR	NULL
construct	NULL
and	NULL
cultivated	NULL
in	NULL
a	NULL
medium	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
cadmium	NULL
chloride	NULL
(	NULL
CdCl	NULL
;	NULL
)	NULL
have	NULL
indeed	NULL
indicated	NULL
a	NULL
positive	NULL
correlation	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
functionally	NULL
active	NULL
Tax	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
heavy-metal	NULL
ions	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
was	NULL
assayed	NULL
by	NULL
RT-PCR	NULL
performed	NULL
on	NULL
total	NULL
mRNA	NULL
extracted	NULL
after	NULL
a	NULL
24-h	NULL
culture	NULL
of	NULL
cells	NULL
either	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
5	NULL
or	NULL
10	NULL
wM	NULL
CdCl	NULL
;	NULL
with	NULL
or	NULL
without	NULL
100	NULL
wM	NULL
PDTC	NULL
,	NULL
an	NULL
antioxidant	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
the	NULL
mobilization	NULL
of	NULL
by	NULL
Tax	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
,	NULL
VCAM-1	NULL
mRNA	NULL
was	NULL
undetect-able	NULL
,	NULL
whereas	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
TK	NULL
gene	NULL
,	NULL
used	NULL
as	NULL
a	NULL
control	NULL
,	NULL
was	NULL
observed	NULL
.	NULL

After	NULL
treatment	NULL
of	NULL
JPX-9	NULL
cells	NULL
with	NULL
CdCl	NULL
,	NULL
VCAM-1	NULL
mRNA	NULL
was	NULL
readily	NULL
detected	NULL
at	NULL
both	NULL
Cd**	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Tax	NULL
induction	NULL
on	NULL
the	NULL
membrane	NULL
expression	NULL
of	NULL
CD	NULL
106	NULL
CD	NULL
25	NULL
3	NULL
»	NULL
188	NULL
89.7	NULL
%	NULL
4	NULL
i	NULL
34.9	NULL
%	NULL
1	NULL
|	NULL
&	NULL
Relative	NULL
Cell	NULL
Number	NULL
109	NULL
a_	NULL
_-	NULL
.	NULL

100	NULL
76.6	NULL
%	NULL
Fluorescence	NULL
Intensity	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
VCAM-1	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
from	NULL
one	NULL
HAM/TSP	NULL
patient	NULL
.	NULL

Freshly	NULL
isolated	NULL
T	NULL
cells	NULL
from	NULL
this	NULL
patient	NULL
(	NULL
A	NULL
)	NULL
and	NULL
T	NULL
cells	NULL
obtained	NULL
from	NULL
a	NULL
normal	NULL
blood	NULL
donor	NULL
,	NULL
activated	NULL
with	NULL
phytohemagglutinin	NULL
,	NULL
and	NULL
then	NULL
cultured	NULL
in	NULL
growth	NULL
medium	NULL
supplemented	NULL
with	NULL
IL-2	NULL
(	NULL
B	NULL
)	NULL
were	NULL
labeled	NULL
either	NULL
with	NULL
a	NULL
MAb	NULL
to	NULL
VCAM-1	NULL
(	NULL
1G11	NULL
)	NULL
or	NULL
with	NULL
a	NULL
MAb	NULL
to	NULL
CD25	NULL
(	NULL
B1.49.9	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
FITC-conjugated	NULL
anti-mouse	NULL
Ig	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Fluorescence	NULL
profiles	NULL
of	NULL
cells	NULL
labeled	NULL
with	NULL
the	NULL
appropriate	NULL
IgG	NULL
isotype	NULL
are	NULL
shown	NULL
as	NULL
controls	NULL
.	NULL

Where	NULL
relevant	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
is	NULL
indicated	NULL
.	NULL

vou	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
A	NULL
3	NULL
JuRKAT	NULL
®	NULL
co	NULL
E	NULL
G	NULL
;	NULL
8	NULL
G	NULL
;	NULL
10	NULL
'	NULL
102	NULL
.	NULL

10°	NULL
16	NULL
``	NULL
2	NULL
=	NULL
©	NULL
®	NULL
@	NULL
Z	NULL
£	NULL
ci1	NULL
®	NULL
Ei2	NULL
®	NULL
G	NULL
ak	NULL
&	NULL
e	NULL
3	NULL
O	NULL
md	NULL
Fluorescence	NULL
Intensity	NULL
Tax-INDUCED	NULL
VCAM-1	NULL
EXPRESSION	NULL
BY	NULL
T	NULL
CELLS	NULL
-	NULL
8525	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
R	NULL
6	NULL
ae	NULL
--	NULL
Cie	NULL
H4	NULL
)	NULL
wage	NULL
0+	NULL
VCAM-1	NULL
-	NULL
a	NULL
»	NULL
dB	NULL
ame	NULL
|	NULL
Tax	NULL
50	NULL
o	NULL
--	NULL
<	NULL
p	NULL
ug	NULL
Actin	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Analysis	NULL
of	NULL
cell	NULL
surface	NULL
VCAM-1	NULL
expression	NULL
by	NULL
Tax-expressing	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
For	NULL
a	NULL
flow	NULL
cytometry	NULL
analysis	NULL
,	NULL
Jurkat	NULL
parental	NULL
cells	NULL
,	NULL
a	NULL
Tax-negative	NULL
Jurkat	NULL
clone	NULL
(	NULL
C9	NULL
)	NULL
,	NULL
and	NULL
Tax-positive	NULL
Jurkat	NULL
clones	NULL
(	NULL
C11	NULL
,	NULL
E12	NULL
,	NULL
and	NULL
clone	NULL
50	NULL
)	NULL
were	NULL
labeled	NULL
with	NULL
a	NULL
MAb	NULL
to	NULL
VCAM-1	NULL
(	NULL
1G11	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
FITC-conjugated	NULL
anti-mouse	NULL
Ig	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Fluorescence	NULL
profiles	NULL
are	NULL
shown	NULL
as	NULL
dark	NULL
histograms	NULL
after	NULL
labeling	NULL
with	NULL
the	NULL
VCAM-1	NULL
MAb	NULL
and	NULL
as	NULL
light	NULL
histograms	NULL
after	NULL
labeling	NULL
with	NULL
an	NULL
IgG1	NULL
isotype	NULL
control	NULL
.	NULL

The	NULL
results	NULL
are	NULL
representative	NULL
of	NULL
3	NULL
to	NULL
10	NULL
separate	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
For	NULL
an	NULL
immunoblot	NULL
analysis	NULL
,	NULL
lysates	NULL
prepared	NULL
from	NULL
parental	NULL
Jurkat	NULL
and	NULL
C9	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
from	NULL
Tax-positive	NULL
T	NULL
cells	NULL
,	NULL
C11	NULL
,	NULL
E12	NULL
,	NULL
50	NULL
,	NULL
and	NULL
C8166	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
6	NULL
)	NULL
,	NULL
were	NULL
electrophoresed	NULL
through	NULL
an	NULL
SDS-7.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
under	NULL
nonreducing	NULL
conditions	NULL
and	NULL
then	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
first	NULL
with	NULL
a	NULL
VCAM-1	NULL
MAb	NULL
(	NULL
1.4C3	NULL
)	NULL
,	NULL
then	NULL
with	NULL
a	NULL
rabbit	NULL
anti-Tax	NULL
antiserum	NULL
and	NULL
with	NULL
a	NULL
rabbit	NULL
anti-actin	NULL
antiserum	NULL
,	NULL
and	NULL
then	NULL
with	NULL
a	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-mouse	NULL
or	NULL
anti-rabbit	NULL
Ig	NULL
antibody	NULL
.	NULL

Proteins	NULL
were	NULL
revealed	NULL
by	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
and	NULL
after	NULL
exposure	NULL
of	NULL
the	NULL
membrane	NULL
to	NULL
hyperfilms	NULL
.	NULL

VCAM-1	NULL
was	NULL
next	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
that	NULL
of	NULL
VCAM-1	NULL
(	NULL
CD106	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
that	NULL
of	NULL
B7	NULL
(	NULL
CD80	NULL
)	NULL
,	NULL
a	NULL
Tax-inducible	NULL
membrane	NULL
antigen	NULL
(	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
)	NULL
,	NULL
were	NULL
determined	NULL
on	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
ZnCl	NULL
;	NULL
or	NULL
CdCl	NULL
;	NULL
,	NULL
.	NULL

The	NULL
same	NULL
analysis	NULL
(	NULL
except	NULL
for	NULL
B7	NULL
)	NULL
performed	NULL
with	NULL
parental	NULL
Jurkat	NULL
T	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
ZnCl	NULL
,	NULL
revealed	NULL
that	NULL
VCAM-1	NULL
could	NULL
not	NULL
be	NULL
induced	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
untreated	NULL
JPX-9	NULL
cells	NULL
,	NULL
neither	NULL
VCAM-1	NULL
nor	NULL
B7	NULL
(	NULL
CD80	NULL
)	NULL
was	NULL
expressed	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Following	NULL
Tax	NULL
induction	NULL
by	NULL
CdCl	NULL
,	NULL
or	NULL
ZnCl	NULL
,	NULL
,	NULL
JPX-9	NULL
cells	NULL
expressing	NULL
either	NULL
VCAM-1	NULL
or	NULL
B7	NULL
were	NULL
detected	NULL
,	NULL
at	NULL
a	NULL
percentage	NULL
about	NULL
fourfold	NULL
higher	NULL
for	NULL
cells	NULL
treated	NULL
with	NULL
ZnCl	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
than	NULL
for	NULL
those	NULL
treated	NULL
with	NULL
CdCl	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

No	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
JPX-9	NULL
cells	NULL
expressing	NULL
CD4	NULL
was	NULL
observed	NULL
following	NULL
Tax	NULL
induc-tion	NULL
.	NULL

These	NULL
results	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
data	NULL
obtained	NULL
by	NULL
RT-PCR	NULL
analysis	NULL
,	NULL
confirmed	NULL
that	NULL
Tax	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
for	NULL
transactivation	NULL
by	NULL
Tax	NULL
.	NULL

To	NULL
further	NULL
ascertain	NULL
the	NULL
role	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
,	NULL
we	NULL
next	NULL
attempted	NULL
to	NULL
localize	NULL
the	NULL
Tax-responsive	NULL
elements	NULL
in	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
three	NULL
deletion	NULL
constructs	NULL
that	NULL
contained	NULL
portions	NULL
of	NULL
the	NULL
VCAM-1	NULL
5'-flanking	NULL
sequences	NULL
,	NULL
-2167	NULL
(	NULL
Ff1	NULL
)	NULL
,	NULL
=-98	NULL
(	NULL
F3	NULL
)	NULL
,	NULL
and	NULL
-44	NULL
(	NULL
F4	NULL
)	NULL
,	NULL
linked	NULL
to	NULL
the	NULL
promot-erless	NULL
CAT	NULL
gene	NULL
were	NULL
transiently	NULL
transfected	NULL
by	NULL
electroporation	NULL
either	NULL
into	NULL
CEM	NULL
lymphoblastoid	NULL
T	NULL
cells	NULL
or	NULL
into	NULL
JPX-9	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
Tax	NULL
,	NULL
CEM	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
Tax	NULL
expression	NULL
plasmid	NULL
whereas	NULL
JPX-9	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
CdCJ	NULL
,	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
CAT	NULL
assays	NULL
performed	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
revealed	NULL
that	NULL
Tax	NULL
strongly	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
in	NULL
CEM	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Ff1	NULL
and	NULL
F3	NULL
constructs	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
-2167	NULL
to	NULL
-98	NULL
region	NULL
are	NULL
dispensable	NULL
for	NULL
Tax	NULL
transactivation	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
.	NULL

However	NULL
,	NULL
with	NULL
re	NULL
gard	NULL
to	NULL
JPX-9	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
constructs	NULL
and	NULL
treated	NULL
with	NULL
CdCl	NULL
;	NULL
,	NULL
,	NULL
CAT	NULL
assays	NULL
reveal	NULL
that	NULL
a	NULL
responsive	NULL
element	NULL
appears	NULL
to	NULL
exist	NULL
in	NULL
the	NULL
region	NULL
extending	NULL
from	NULL
positions	NULL
-2167	NULL
to	NULL
=98	NULL
of	NULL
the	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

This	NULL
discrepancy	NULL
,	NULL
100uM	NULL
PDTC	NULL
(	NULL
uM	NULL
)	NULL
:	NULL
VCAM-1	NULL
mRNA	NULL
-	NULL
#	NULL
>	NULL
Tax	NULL
mRNA	NULL
@	NULL
m	NULL
&	NULL
>	NULL
TK	NULL
i	NULL
»	NULL
1°	NULL
20	NULL
3	NULL
4	NULL
5	NULL
6	NULL
-	NULL
7	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

VCAM-1	NULL
mRNA	NULL
analysis	NULL
in	NULL
JPX-9	NULL
cells	NULL
treated	NULL
with	NULL
cadmium	NULL
.	NULL

PCR	NULL
analysis	NULL
of	NULL
retrotranscribed	NULL
VCAM-1	NULL
mRNA	NULL
in	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
medium	NULL
containing	NULL
5	NULL
M	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
10	NULL
M	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
CdCl	NULL
;	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
VCAM-1	NULL
oligonucleotide	NULL
primer	NULL
pair	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Meth-ods	NULL
)	NULL
.	NULL

Amplified	NULL
products	NULL
were	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
an	NULL
-*°P-labelled	NULL
VCAM-1	NULL
probe	NULL
.	NULL

Labelled	NULL
DNA	NULL
products	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Autoradiograms	NULL
of	NULL
PCR	NULL
amplification	NULL
of	NULL
retrotranscribed	NULL
Tax	NULL
mRNA	NULL
and	NULL
thymidine	NULL
kinase	NULL
(	NULL
TK	NULL
)	NULL
mRNA	NULL
are	NULL
shown	NULL
as	NULL
controls	NULL
.	NULL

Lane	NULL
1	NULL
represents	NULL
a	NULL
control	NULL
in	NULL
which	NULL
an	NULL
RNA-free	NULL
sample	NULL
was	NULL
treated	NULL
like	NULL
the	NULL
extracted	NULL
samples	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PCR	NULL
analysis	NULL
of	NULL
retrotranscribed	NULL
VCAM-1	NULL
mRNA	NULL
in	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
medium	NULL
containing	NULL
5	NULL
or	NULL
10	NULL
M	NULL
CdCl	NULL
,	NULL
and	NULL
100	NULL
LM	NULL
PDTC	NULL
is	NULL
shown	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

8526	NULL
VALENTIN	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

IgG1	NULL
(	NULL
control	NULL
)	NULL
CD4	NULL
€D106	NULL
(	NULL
VCAM-1	NULL
)	NULL
CD80	NULL
(	NULL
B7	NULL
)	NULL
A	NULL
if	NULL
A	NULL
jﬁ	NULL
|	NULL
(	NULL
[	NULL
1	NULL
A	NULL
“	NULL
a	NULL
1f	NULL
%	NULL
1	NULL
%	NULL
.	NULL
}	NULL

#	NULL
%	NULL
(	NULL
1	NULL
J	NULL
1	NULL
sf	NULL
L3	NULL
X_	NULL
.	NULL

¢	NULL
160	NULL
164	NULL
162	NULL
10	NULL
>	NULL
104	NULL
180	NULL
16	NULL
%	NULL
162	NULL
16s	NULL
TB	NULL
!	NULL

184°	NULL
T5	NULL
T	NULL
TGs	NULL
Th=	NULL
a	NULL
s.	NULL
&	NULL
_	NULL
@	NULL
.	NULL

@	NULL
©	NULL
B	NULL
2	NULL
A	NULL
=	NULL
2	NULL
®	NULL
``	NULL
g	NULL
fll	NULL
62.2	NULL
%	NULL
64.1	NULL
%	NULL
3	NULL
2	NULL
``	NULL
A	NULL
;	NULL
1	NULL
|	NULL
'	NULL
A	NULL
?	NULL

f	NULL
A	NULL
3	NULL
V	NULL
(	NULL
I	NULL
C	NULL
¥	NULL
\	NULL
j	NULL
l	NULL
Mkk	NULL
n	NULL
@	NULL
-	NULL
f	NULL
E	NULL
16	NULL
isn	NULL
adr	NULL
GBP	NULL
ist	NULL
id	NULL
``	NULL
Ga	NULL
d	NULL
#	NULL
dm	NULL
ast	NULL
diss	NULL
ios	NULL
dor	NULL
dor	NULL
bof	NULL
16°	NULL
dof	NULL
dorf	NULL
dd	NULL
ds	NULL
``	NULL
&	NULL
C	NULL
§	NULL
,	NULL
8	NULL
,	NULL
§	NULL
,	NULL
3	NULL
a	NULL
c	NULL
5	NULL
§	NULL
§	NULL
4	NULL
)	NULL
[	NULL
L	NULL
]	NULL
13.9	NULL
%	NULL
15.8	NULL
%	NULL
ift	NULL
]	NULL
]	NULL
§	NULL
%	NULL
j	NULL
kk	NULL
5	NULL
To	NULL
#	NULL
16	NULL
ur	NULL
Cw	NULL
F	NULL
uF	NULL
iw	NULL
le	NULL
Te	NULL
ib	NULL
as	NULL
Ge	NULL
do	NULL
ad	NULL
iof	NULL
die	NULL
(	NULL
et	NULL
ad	NULL
``	NULL
Fluorescence	NULL
Intensity	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
cell	NULL
surface	NULL
VCAM-1	NULL
expression	NULL
by	NULL
JPX9	NULL
cells	NULL
and	NULL
by	NULL
parental	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
that	NULL
of	NULL
VCAM-1	NULL
(	NULL
CD106	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD4	NULL
and	NULL
that	NULL
of	NULL
B7	NULL
(	NULL
CD80	NULL
)	NULL
were	NULL
determined	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
medium	NULL
containing	NULL
ZnCl	NULL
,	NULL
(	NULL
A	NULL
)	NULL
or	NULL
on	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
medium	NULL
containing	NULL
either	NULL
ZnCl	NULL
,	NULL
(	NULL
B	NULL
)	NULL
or	NULL
CdCl	NULL
;	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
labeled	NULL
with	NULL
an	NULL
isotype	NULL
control	NULL
IgG1	NULL
MAb	NULL
,	NULL
with	NULL
an	NULL
anti-CD4	NULL
MAb	NULL
(	NULL
IOT4	NULL
)	NULL
,	NULL
with	NULL
an	NULL
anti-B7	NULL
MAb	NULL
(	NULL
104	NULL
)	NULL
(	NULL
except	NULL
for	NULL
parental	NULL
Jurkat	NULL
T	NULL
cells	NULL
)	NULL
,	NULL
and	NULL
with	NULL
an	NULL
anti-VCAM-1	NULL
MAb	NULL
(	NULL
1G11	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
incubated	NULL
with	NULL
an	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Fluorescence	NULL
profiles	NULL
before	NULL
treatment	NULL
are	NULL
shown	NULL
as	NULL
controls	NULL
.	NULL

Where	NULL
relevant	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
positive	NULL
cells	NULL
is	NULL
indicated	NULL
.	NULL

which	NULL
might	NULL
be	NULL
related	NULL
to	NULL
a	NULL
difference	NULL
in	NULL
the	NULL
efficiency	NULL
of	NULL
Tax	NULL
either	NULL
transiently	NULL
or	NULL
stably	NULL
expressed	NULL
,	NULL
warrants	NULL
further	NULL
investi-gations	NULL
.	NULL

For	NULL
both	NULL
types	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
F4	NULL
construct	NULL
,	NULL
no	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
Tax	NULL
was	NULL
observed	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
major	NULL
Tax-responsive	NULL
elements	NULL
in	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
were	NULL
found	NULL
between	NULL
-98	NULL
and	NULL
-44	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
region	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
two	NULL
sequences	NULL
,	NULL
one	NULL
at	NULL
-57	NULL
and	NULL
the	NULL
other	NULL
at	NULL
-72	NULL
,	NULL
that	NULL
each	NULL
conform	NULL
to	NULL
consensus	NULL
NF-kB	NULL
elements	NULL
(	NULL
36	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
which	NULL
of	NULL
these	NULL
elements	NULL
is	NULL
essential	NULL
to	NULL
Tax-induced	NULL
VCAM-1	NULL
expression	NULL
,	NULL
we	NULL
used	NULL
two	NULL
mutant	NULL
constructs	NULL
generated	NULL
from	NULL
the	NULL
F3	NULL
deletion	NULL
plasmid	NULL
(	NULL
F3mA	NULL
and	NULL
F3mB	NULL
)	NULL
.	NULL

Transfection	NULL
experiments	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
indicated	NULL
that	NULL
with	NULL
the	NULL
upstream	NULL
F3mA	NULL
construct	NULL
,	NULL
no	NULL
CAT	NULL
activity	NULL
was	NULL
induced	NULL
in	NULL
presence	NULL
of	NULL
Tax	NULL
.	NULL

The	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
F3mB	NULL
mutant	NULL
.	NULL

These	NULL
data	NULL
clearly	NULL
demonstrate	NULL
that	NULL
the	NULL
Tax-induced	NULL
expression	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
two	NULL
NF-kB	NULL
consensus	NULL
binding	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
-98	NULL
to	NULL
-44	NULL
region	NULL
of	NULL
the	NULL
core	NULL
promoter	NULL
.	NULL

Tax	NULL
induces	NULL
VCAM-1	NULL
expression	NULL
through	NULL
the	NULL
NF-KB	NULL
pathway	NULL
.	NULL

Since	NULL
Tax	NULL
is	NULL
known	NULL
to	NULL
intervene	NULL
in	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
NF-kB	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
we	NULL
next	NULL
performed	NULL
gel	NULL
shift	NULL
assays	NULL
to	NULL
demonstrate	NULL
the	NULL
specific	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
two	NULL
sites	NULL
.	NULL

A	NULL
labeled	NULL
oligonucleotide	NULL
encompassing	NULL
these	NULL
two	NULL
elements	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
either	NULL
from	NULL
parental	NULL
Jurkat	NULL
cells	NULL
or	NULL
from	NULL
JPX-9	NULL
cells	NULL
,	NULL
both	NULL
cell	NULL
types	NULL
being	NULL
either	NULL
left	NULL
uninduced	NULL
or	NULL
treated	NULL
with	NULL
5	NULL
M	NULL
CdCl	NULL
;	NULL
,	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lane	NULL
4	NULL
,	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
shift	NULL
of	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
was	NULL
observed	NULL
when	NULL
it	NULL
was	NULL
mixed	NULL
with	NULL
extracts	NULL
of	NULL
treated	NULL
JPX-9	NULL
cells	NULL
compared	NULL
with	NULL
extracts	NULL
prepared	NULL
either	NULL
from	NULL
untreated	NULL
JPX-9	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
from	NULL
parental	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
CdCl	NULL
;	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
a	NULL
10-	NULL
,	NULL
50-	NULL
,	NULL
or	NULL
100-fold	NULL
molecular	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
decreased	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
Tax-inducible	NULL
DNA-protein	NULL
complex	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
such	NULL
inhibition	NULL
was	NULL
observed	NULL
after	NULL
incubation	NULL
of	NULL
the	NULL
nuclear	NULL
proteins	NULL
and	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
Sp-1	NULL
oligonucleotide	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
.	NULL

A	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
the	NULL
DNA-protein	NULL
complex	NULL
was	NULL
also	NULL
observed	NULL
with	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
JPX-9	NULL
cells	NULL
treated	NULL
with	NULL
CdCJ	NULL
;	NULL
,	NULL
and	NULL
with	NULL
100	NULL
M	NULL
PDTC	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
treatment	NULL
of	NULL
Tax-expressing	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
PDTC	NULL
led	NULL
to	NULL
a	NULL
dose-dependent	NULL
decrease	NULL
in	NULL
VCAM-1	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
VCAM-1	NULL
expression	NULL
was	NULL
inhibited	NULL
by	NULL
more	NULL
than	NULL
75	NULL
%	NULL
at	NULL
the	NULL
highest	NULL
concentration	NULL
of	NULL
PDTC	NULL
(	NULL
100	NULL
wM	NULL
)	NULL
.	NULL

Such	NULL
an	NULL
effect	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
a	NULL
decreased	NULL
functionality	NULL
of	NULL
Tax	NULL
,	NULL
since	NULL
Tax	NULL
was	NULL
found	NULL
to	NULL
be	NULL
still	NULL
able	NULL
to	NULL
trans-activate	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
results	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
nuclear	NULL
proteins	NULL
binding	NULL
specifically	NULL
to	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
xB	NULL
consensus	NULL
sites	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
promoter	NULL
in	NULL
Tax-expressing	NULL
T	NULL
cells	NULL
.	NULL

They	NULL
further	NULL
underline	NULL
that	NULL
these	NULL
two	NULL
sites	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
Tax-mediated	NULL
induction	NULL
of	NULL
the	NULL
VCAM-1	NULL
expression	NULL
on	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Infiltration	NULL
of	NULL
T	NULL
lymphocytes	NULL
carrying	NULL
the	NULL
HTLV-1	NULL
provirus	NULL
into	NULL
organs	NULL
represents	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
the	NULL
evolution	NULL
of	NULL
lymphoproliferative	NULL
and	NULL
inflammatory	NULL
diseases	NULL
associated	NULL
with	NULL
HTLV-1	NULL
infection	NULL
.	NULL

Indeed	NULL
,	NULL
numerous	NULL
studies	NULL
have	NULL
underlined	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
Tax-INDUCED	NULL
VCAM-1	NULL
EXPRESSION	NULL
BY	NULL
T	NULL
CELLS	NULL
-	NULL
8527	NULL
A	NULL
)	NULL
API	NULL
GATA	NULL
NF-xB	NULL
_	NULL
TATAA	NULL
CAT	NULL
Fi-pCAT3	NULL
w	NULL
~2167	NULL
NF-xB	NULL
_	NULL
TATAA	NULL
CAT	NULL
F3-pCAT3	NULL
»	NULL
_22	NULL
I	NULL
!	NULL

~	NULL
wom	NULL
NF-	NULL
«	NULL
B	NULL
_	NULL
TATAA	NULL
CAT	NULL
F3mA-pCAT3	NULL
so	NULL
_	NULL
M	NULL
(	NULL
*	NULL
mm	NULL
NF-xB	NULL
_	NULL
TATAA	NULL
CAT	NULL
FamB-pCAT3	NULL
-	NULL
38	NULL
MELLE—	NULL
TATAA	NULL
CAT	NULL
F4-pCAT3	NULL
~	NULL
44	NULL
1—1	NULL
:	NULL
—	NULL
B	NULL
)	NULL
Cd2*	NULL
induced	NULL
Tax	NULL
:	NULL
tog	NULL
0	NULL
-	NULL
#	NULL
00	NULL
+	NULL
%	NULL
00	NULL
-	NULL
&	NULL
oc	NULL
%	NULL
Tax	NULL
:	NULL
«	NULL
og	NULL
0	NULL
-o	NULL
#	NULL
0008	NULL
40009	NULL
¢	NULL
0+	NULL
125	NULL
g	NULL
12s	NULL
-£	NULL
100	NULL
é	NULL
100	NULL
é	NULL
e	NULL
E	NULL
so	NULL
.	NULL
}	NULL

so	NULL
.l	NULL
3	NULL
»	NULL
¥	NULL
8	NULL
75	NULL
A	NULL
o	NULL
§	NULL
f	NULL
3	NULL
s	NULL
$	NULL
&	NULL
s	NULL
-G	NULL
a*	NULL
h	NULL
a	NULL
-	NULL
``	NULL
as	NULL
4	NULL
25	NULL
$	NULL
3	NULL
é	NULL
‘	NULL
b	NULL
K	NULL
's	NULL
0°	NULL
a*	NULL
``	NULL
of	NULL
_P	NULL
``	NULL
gm	NULL
aP	NULL
AS	NULL
A8	NULL
V3	NULL
¥~	NULL
$	NULL
§ﬁ	NULL
V	NULL
‘	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Analysis	NULL
of	NULL
Tax-responsive	NULL
elements	NULL
in	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
diagram	NULL
,	NULL
adapted	NULL
from	NULL
reference	NULL
36	NULL
,	NULL
of	NULL
the	NULL
fusion	NULL
plasmids	NULL
containing	NULL
portions	NULL
of	NULL
VCAM-1	NULL
-flanking	NULL
sequence	NULL
with	NULL
or	NULL
without	NULL
deletion	NULL
mutations	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
and	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CEM	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
VCAM-1	NULL
wild-type	NULL
Ff1-pCAT3	NULL
construct	NULL
,	NULL
deletion	NULL
plasmids	NULL
F3-pCAT3	NULL
(	NULL
-98	NULL
)	NULL
and	NULL
F4-pCAT3	NULL
(	NULL
-44	NULL
)	NULL
,	NULL
or	NULL
mutant	NULL
F3mA-pCAT3	NULL
or	NULL
F3mB-pCAT3	NULL
construct	NULL
or	NULL
cotransfected	NULL
with	NULL
one	NULL
of	NULL
these	NULL
constructs	NULL
and	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Promoter	NULL
transactivation	NULL
was	NULL
evaluated	NULL
by	NULL
measuring	NULL
CAT	NULL
antigen	NULL
synthesis	NULL
by	NULL
a	NULL
CAT	NULL
antigen	NULL
capture	NULL
assay	NULL
.	NULL

Bars	NULL
represent	NULL
the	NULL
average	NULL
value	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
JPX-9	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
same	NULL
reporter	NULL
plasmids	NULL
as	NULL
in	NULL
panel	NULL
B	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
supplemented	NULL
or	NULL
not	NULL
supplemented	NULL
with	NULL
CdCl	NULL
;	NULL
.	NULL

Promoter	NULL
transactivation	NULL
was	NULL
evaluated	NULL
by	NULL
measuring	NULL
the	NULL
[	NULL
*HJacetylchloramphenicol	NULL
produced	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

We	NULL
provisionally	NULL
considered	NULL
the	NULL
transactivation	NULL
of	NULL
VCAM-1	NULL
wild-type	NULL
(	NULL
Ff1	NULL
)	NULL
promoter	NULL
by	NULL
Tax	NULL
to	NULL
be	NULL
100	NULL
%	NULL
transactivation	NULL
to	NULL
allow	NULL
comparison	NULL
of	NULL
panels	NULL
A	NULL
and	NULL
B	NULL
.	NULL

Under	NULL
similar	NULL
experimental	NULL
conditions	NULL
,	NULL
transactivation	NULL
of	NULL
LTR	NULL
-y	NULL
by	NULL
Tax	NULL
used	NULL
as	NULL
internal	NULL
control	NULL
was	NULL
107.5	NULL
%	NULL
+	NULL
17.5	NULL
%	NULL
.	NULL

the	NULL
role	NULL
of	NULL
adhesion	NULL
molecules	NULL
,	NULL
not	NULL
only	NULL
in	NULL
mediating	NULL
cell-cell	NULL
interactions	NULL
but	NULL
also	NULL
in	NULL
mediating	NULL
tissue	NULL
invasion	NULL
(	NULL
18	NULL
,	NULL
20-22	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
55	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
VCAM-1	NULL
,	NULL
an	NULL
adhesion	NULL
molecule	NULL
that	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
Ig	NULL
gene	NULL
superfamily	NULL
,	NULL
is	NULL
expressed	NULL
on	NULL
in	NULL
vitro	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
,	NULL
on	NULL
T	NULL
cells	NULL
from	NULL
one	NULL
HAM/TSP	NULL
patient	NULL
,	NULL
and	NULL
on	NULL
Jurkat	NULL
T	NULL
cells	NULL
stably	NULL
expressing	NULL
the	NULL
viral	NULL
regulatory	NULL
Tax	NULL
protein	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
Tax	NULL
activates	NULL
VCAM-1	NULL
transcription	NULL
mainly	NULL
via	NULL
the	NULL
two	NULL
NF-KB	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
.	NULL

Among	NULL
the	NULL
in	NULL
vitro	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
examined	NULL
in	NULL
this	NULL
study	NULL
and	NULL
which	NULL
were	NULL
found	NULL
to	NULL
express	NULL
VCAM-1	NULL
,	NULL
C8166	NULL
cells	NULL
were	NULL
known	NULL
to	NULL
harbor	NULL
a	NULL
deleted	NULL
HTLV-1	NULL
provirus	NULL
.	NULL

Because	NULL
the	NULL
only	NULL
viral	NULL
protein	NULL
synthesized	NULL
by	NULL
these	NULL
cells	NULL
is	NULL
Tax	NULL
,	NULL
we	NULL
next	NULL
investigated	NULL
its	NULL
role	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
by	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
this	NULL
regulatory	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
HTLV-1	NULL
infection	NULL
(	NULL
10	NULL
,	NULL
56	NULL
)	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
have	NULL
used	NULL
three	NULL
clones	NULL
of	NULL
the	NULL
human	NULL
Jurkat	NULL
T-cell	NULL
line	NULL
which	NULL
share	NULL
the	NULL
property	NULL
to	NULL
stably	NULL
express	NULL
Tax	NULL
and	NULL
found	NULL
that	NULL
VCAM-1	NULL
was	NULL
present	NULL
on	NULL
these	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
Tax	NULL
in	NULL
JPX-9	NULL
cells	NULL
,	NULL
a	NULL
subclone	NULL
of	NULL
Jurkat	NULL
cells	NULL
stably	NULL
transformed	NULL
with	NULL
a	NULL
plasmid	NULL
carrying	NULL
the	NULL
tax	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
inducible	NULL
human	NULL
metallothionein	NULL
promoter	NULL
,	NULL
led	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
stress	NULL
that	NULL
Tax	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
on	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
.	NULL

Indeed	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
anergized	NULL
autoreactive	NULL
T	NULL
cells	NULL
bearing	NULL
TCR-y8	NULL
(	NULL
26	NULL
)	NULL
,	NULL
VCAM-1	NULL
has	NULL
never	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
by	NULL
resting	NULL
or	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

As	NULL
such	NULL
,	NULL
the	NULL
present	NULL
observations	NULL
indicate	NULL
a	NULL
unique	NULL
effect	NULL
of	NULL
Tax	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
an	NULL
adhesion	NULL
molecule	NULL
,	NULL
since	NULL
other	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
ICAM-1	NULL
,	NULL
LFA-3	NULL
and	NULL
L-selectin	NULL
expressed	NULL
by	NULL
normal	NULL
T	NULL
cells	NULL
are	NULL
upregulated	NULL
by	NULL
Tax	NULL
on	NULL
T	NULL
cells	NULL
carrying	NULL
proviral	NULL
HTLV-1	NULL
(	NULL
50	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
should	NULL
be	NULL
underlined	NULL
that	NULL
HTLV-1-transformed	NULL
T	NULL
cells	NULL
constitutively	NULL
express	NULL
both	NULL
VCAM-1	NULL
and	NULL
its	NULL
ligand	NULL
VLA-4	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
same	NULL
is	NULL
true	NULL
for	NULL
OX40	NULL
and	NULL
its	NULL
ligand	NULL
gp34	NULL
,	NULL
which	NULL
are	NULL
both	NULL
detected	NULL
on	NULL
the	NULL
membrane	NULL
of	NULL
Tax-expressing	NULL
T	NULL
lymphocytes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
2.1-kb	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
8528	NULL
VALENTIN	NULL
ET	NULL
AL	NULL
.	NULL

CdCI2	NULL
(	NULL
5uM	NULL
)	NULL
~o	NULL
40	NULL
~	NULL
o	NULL
o4	NULL
0+	NULL
to	NULL
+	NULL
+	NULL
+	NULL
PDTC	NULL
(	NULL
100pM	NULL
)	NULL
mo	NULL
0	NULL
mo	NULL
to	NULL
``	NULL
to	NULL
*	NULL
%	NULL
mo	NULL
m	NULL
o	NULL
mo	NULL
f	NULL
Competitor	NULL
oe	NULL
NF-xB	NULL
Sp-1	NULL
1	NULL
203	NULL
4	NULL
5	NULL
7	NULL
8	NULL
9	NULL
10	NULL
NF-	NULL
«	NULL
B	NULL
a	NULL
»	NULL
tbat	NULL
u	NULL
tnd	NULL
n	NULL
Wt	NULL
io	NULL
tut	NULL
Free	NULL
probe	NULL
i	NULL
»	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B-binding	NULL
proteins	NULL
in	NULL
JPX-9	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
CdCl	NULL
,	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
5	NULL
M	NULL
CdCl	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
5	NULL
aM	NULL
CdCl	NULL
,	NULL
and	NULL
100	NULL
M	NULL
PDTC	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
were	NULL
reacted	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
JPX-9	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
containing	NULL
5	NULL
wM	NULL
CdCl	NULL
,	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
10-	NULL
,	NULL
50-	NULL
,	NULL
and	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cither	NULL
the	NULL
same	NULL
unlabeled	NULL
double-stranded	NULL
NF-B	NULL
oligonucleotide	NULL
sequence	NULL
(	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
)	NULL
or	NULL
100-fold	NULL
unlabeled	NULL
double-stranded	NULL
Sp-1	NULL
oligonucleotide	NULL
(	NULL
lanes	NULL
10	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
5	NULL
M	NULL
CdCl	NULL
;	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
reacted	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
NF-	NULL
«	NULL
B	NULL
probe	NULL
are	NULL
shown	NULL
as	NULL
controls	NULL
.	NULL

VCAM-1	NULL
gene	NULL
,	NULL
performed	NULL
with	NULL
the	NULL
respective	NULL
CAT	NULL
reporter	NULL
constructs	NULL
transfected	NULL
either	NULL
in	NULL
CEM	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
Tax	NULL
expression	NULL
plasmid	NULL
or	NULL
in	NULL
JPX-9	NULL
cells	NULL
either	NULL
induced	NULL
or	NULL
left	NULL
uninduced	NULL
,	NULL
revealed	NULL
that	NULL
Tax	NULL
was	NULL
inducing	NULL
VCAM-1	NULL
expression	NULL
in	NULL
a	NULL
B-dependent	NULL
manner	NULL
.	NULL

Indeed	NULL
,	NULL
these	NULL
experiments	NULL
indicated	NULL
that	NULL
the	NULL
-98	NULL
to	NULL
-44	NULL
region	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
,	NULL
which	NULL
contained	NULL
two	NULL
sequences	NULL
that	NULL
conform	NULL
to	NULL
consensus	NULL
NF-kB	NULL
elements	NULL
,	NULL
is	NULL
indispensable	NULL
for	NULL
Tax-induced	NULL
expression	NULL
of	NULL
VCAM-1	NULL
.	NULL

Next	NULL
,	NULL
transfection	NULL
of	NULL
two	NULL
CAT	NULL
constructs	NULL
,	NULL
each	NULL
carrying	NULL
the	NULL
-98	NULL
to	NULL
-44	NULL
region	NULL
mutated	NULL
in	NULL
either	NULL
NF-	NULL
«	NULL
kB-like	NULL
site	NULL
,	NULL
indicated	NULL
that	NULL
both	NULL
of	NULL
them	NULL
were	NULL
strictly	NULL
required	NULL
for	NULL
Tax	NULL
induction	NULL
of	NULL
this	NULL
adhesion	NULL
molecule	NULL
.	NULL

Furthermore	NULL
,	NULL
gel	NULL
shift	NULL
assays	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
either	NULL
induced	NULL
or	NULL
uninduced	NULL
JPX-9	NULL
cells	NULL
confirmed	NULL
that	NULL
Tax	NULL
induction	NULL
correlated	NULL
with	NULL
the	NULL
formation	NULL
of	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
oligonucleotide	NULL
spanning	NULL
these	NULL
two	NULL
NF-	NULL
«	NULL
B-like	NULL
sequences	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
protein-DNA	NULL
complexes	NULL
was	NULL
found	NULL
to	NULL
be	NULL
linked	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
VCAM-1	NULL
by	NULL
induced	NULL
JPX-9	NULL
cells	NULL
treated	NULL
with	NULL
the	NULL
antioxidant	NULL
PDTC	NULL
,	NULL
which	NULL
abolished	NULL
oxidative	NULL
processes	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

VCAM-1	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
an	NULL
adhesion	NULL
molecule	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
IL-1-	NULL
or	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
endothelial	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
established	NULL
that	NULL
the	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
were	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
VCAM-1	NULL
transcription	NULL
by	NULL
these	NULL
inflammatory	NULL
cyto-	NULL
J.	NULL
Viror	NULL
.	NULL

kines	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
two	NULL
sites	NULL
were	NULL
not	NULL
responsive	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
treated	NULL
with	NULL
TNF-	NULL
«	NULL
,	NULL
even	NULL
though	NULL
NF-	NULL
«	NULL
B	NULL
elements	NULL
present	NULL
in	NULL
other	NULL
promoters	NULL
were	NULL
activated	NULL
by	NULL
TNF-a	NULL
in	NULL
these	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
19	NULL
,	NULL
33	NULL
,	NULL
36	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
therefore	NULL
indicated	NULL
that	NULL
NF-kB	NULL
subunits	NULL
specific	NULL
of	NULL
endothelial	NULL
cells	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
response	NULL
of	NULL
the	NULL
VCAM-1	NULL
promoter	NULL
to	NULL
TNF-	NULL
«	NULL
.	NULL

Experiments	NULL
performed	NULL
to	NULL
ascertain	NULL
whether	NULL
IL-1	NULL
or	NULL
IL-6	NULL
added	NULL
to	NULL
Jurkat	NULL
T	NULL
cells	NULL
might	NULL
be	NULL
able	NULL
to	NULL
induce	NULL
VCAM-1	NULL
expression	NULL
consistently	NULL
gave	NULL
negative	NULL
results	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
results	NULL
indicate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
these	NULL
two	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
are	NULL
implicated	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
VCAM-1	NULL
gene	NULL
in	NULL
Tax-positive	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
underlined	NULL
above	NULL
,	NULL
VCAM-1	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
an	NULL
adhesion	NULL
molecule	NULL
induced	NULL
on	NULL
endothelial	NULL
cells	NULL
by	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Indeed	NULL
,	NULL
quiescent	NULL
endothelial	NULL
cells	NULL
normally	NULL
exhibit	NULL
a	NULL
low	NULL
affinity	NULL
for	NULL
circulating	NULL
lymphocytes	NULL
.	NULL

The	NULL
release	NULL
of	NULL
cytokines	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
results	NULL
in	NULL
the	NULL
upregulation	NULL
of	NULL
VCAM-1	NULL
on	NULL
endothelial	NULL
cells	NULL
and	NULL
the	NULL
subsequent	NULL
establishment	NULL
of	NULL
interactions	NULL
of	NULL
VCAM-1	NULL
with	NULL
VLA-4	NULL
expressed	NULL
on	NULL
T	NULL
lymphocytes	NULL
,	NULL
with	NULL
this	NULL
ligand-receptor	NULL
pair	NULL
allowing	NULL
the	NULL
attachment	NULL
of	NULL
lymphocytes	NULL
to	NULL
activated	NULL
endothelium	NULL
.	NULL

Whether	NULL
or	NULL
not	NULL
VCAM-1	NULL
expressed	NULL
on	NULL
HTLV-l-infected	NULL
T	NULL
lymphocytes	NULL
is	NULL
playing	NULL
a	NULL
major	NULL
role	NULL
in	NULL
recruiting	NULL
these	NULL
cells	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
and	NULL
in	NULL
mediating	NULL
their	NULL
passage	NULL
into	NULL
organs	NULL
remains	NULL
questionable	NULL
,	NULL
inasmuch	NULL
as	NULL
the	NULL
«	NULL
4	NULL
chain	NULL
specifying	NULL
the	NULL
VLA-4	NULL
molecule	NULL
was	NULL
not	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
by	NULL
quiescent	NULL
or	NULL
stimulated	NULL
endothelial	NULL
cells	NULL
.	NULL

Although	NULL
it	NULL
might	NULL
be	NULL
postulated	NULL
that	NULL
an	NULL
alternative	NULL
counterreceptor	NULL
for	NULL
VCAM-1	NULL
on	NULL
endothelial	NULL
cells	NULL
is	NULL
promoting	NULL
the	NULL
adhesion	NULL
and	NULL
invasion	NULL
of	NULL
HTLV-1-infected	NULL
T	NULL
lymphocytes	NULL
,	NULL
VCAM-1	NULL
might	NULL
rather	NULL
favor	NULL
the	NULL
interaction	NULL
of	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
among	NULL
themselves	NULL
and	NULL
with	NULL
uninfected	NULL
T	NULL
cells	NULL
expressing	NULL
VLA-4	NULL
.	NULL

Such	NULL
interactions	NULL
may	NULL
lead	NULL
to	NULL
cell	NULL
fusion	NULL
,	NULL
transmission	NULL
of	NULL
HTLV-1	NULL
,	NULL
and/or	NULL
immuno-logical	NULL
destruction	NULL
of	NULL
infected	NULL
cells	NULL
by	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
.	NULL

Recently	NULL
VCAM-1	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
involved	NULL
as	NULL
an	NULL
accessory	NULL
molecule	NULL
or	NULL
potential	NULL
coreceptor	NULL
for	NULL
HTLV-1-induced	NULL
cell	NULL
fusion	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Soon	NULL
after	NULL
its	NULL
identification	NULL
on	NULL
activated	NULL
endothelial	NULL
cells	NULL
,	NULL
VCAM-1	NULL
was	NULL
also	NULL
found	NULL
on	NULL
nonendothe-lial	NULL
cells	NULL
,	NULL
such	NULL
as	NULL
lymphoid	NULL
dendritic	NULL
cells	NULL
,	NULL
tissue	NULL
macrophages	NULL
,	NULL
glial	NULL
cells	NULL
,	NULL
muscle	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
5	NULL
,	NULL
30	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
VCAM-1	NULL
on	NULL
myoblasts	NULL
and	NULL
myotubes	NULL
and	NULL
VLA-4	NULL
induced	NULL
during	NULL
myo-tube	NULL
formation	NULL
were	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
secondary	NULL
myo-genesis	NULL
(	NULL
43	NULL
)	NULL
.	NULL

A	NULL
recent	NULL
report	NULL
indicates	NULL
that	NULL
HTLV-1	NULL
-associated	NULL
inflammatory	NULL
polymyositis	NULL
is	NULL
not	NULL
due	NULL
to	NULL
direct	NULL
infection	NULL
of	NULL
the	NULL
muscle	NULL
fiber	NULL
by	NULL
the	NULL
virus	NULL
but	NULL
,	NULL
rather	NULL
,	NULL
to	NULL
a	NULL
T-cell-mediated	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
T-restricted	NULL
immuno-pathological	NULL
process	NULL
such	NULL
as	NULL
myocytotoxicity	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
HTLV-1-infected	NULL
T	NULL
cells	NULL
expressing	NULL
VCAM-1	NULL
and	NULL
infiltrating	NULL
muscles	NULL
may	NULL
perturb	NULL
the	NULL
myogenic	NULL
process	NULL
at	NULL
the	NULL
origin	NULL
of	NULL
muscle	NULL
disorders	NULL
that	NULL
have	NULL
been	NULL
described	NULL
in	NULL
some	NULL
patients	NULL
suffering	NULL
from	NULL
HAM/TSP	NULL
.	NULL

The	NULL
numerous	NULL
studies	NULL
devoted	NULL
to	NULL
the	NULL
role	NULL
of	NULL
adhesion	NULL
molecules	NULL
have	NULL
indicated	NULL
that	NULL
activation	NULL
of	NULL
leukocytes	NULL
by	NULL
various	NULL
stimuli	NULL
leads	NULL
to	NULL
different	NULL
utilizations	NULL
of	NULL
adhesion	NULL
pathways	NULL
.	NULL

In	NULL
this	NULL
perspective	NULL
,	NULL
the	NULL
results	NULL
presented	NULL
here	NULL
provide	NULL
a	NULL
novel	NULL
example	NULL
in	NULL
which	NULL
activation	NULL
of	NULL
an	NULL
adhesion	NULL
molecule	NULL
such	NULL
as	NULL
VCAM-1	NULL
induced	NULL
by	NULL
a	NULL
viral	NULL
protein	NULL
may	NULL
represent	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
development	NULL
of	NULL
lesions	NULL
associated	NULL
with	NULL
a	NULL
retroviral	NULL
infection	NULL
in	NULL
humans	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
H.V	NULL
.	NULL

and	NULL
LL	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
study	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
T.	NULL
Collins	NULL
(	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
K.	NULL
Sugamura	NULL
(	NULL
Tohoku	NULL
University	NULL
,	NULL
Sendai	NULL
,	NULL
Japan	NULL
)	NULL
,	NULL
and	NULL
C.	NULL
Blanc-Desgranges	NULL
(	NULL
INSERM	NULL
,	NULL
U271	NULL
,	NULL
Lyon	NULL
,	NULL
France	NULL
)	NULL
for	NULL
gifts	NULL
of	NULL
plas-	NULL
voL	NULL
.	NULL

71	NULL
,	NULL
1997	NULL
mids	NULL
or	NULL
cells	NULL
.	NULL

We	NULL
thank	NULL
Madeleine	NULL
Duc	NULL
Dodon	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
institutional	NULL
grants	NULL
from	NULL
the	NULL
Institut	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
Médicale	NULL
(	NULL
INSERM	NULL
)	NULL
,	NULL
the	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
(	NULL
CNRS	NULL
)	NULL
,	NULL
a	NULL
grant	NULL
(	NULL
to	NULL
L.G	NULL
.	NULL
)	NULL

from	NULL
Agence	NULL
Nationale	NULL
de	NULL
Recherches	NULL
sur	NULL
le	NULL
SIDA	NULL
(	NULL
ANRS	NULL
)	NULL
,	NULL
and	NULL
grants	NULL
(	NULL
to	NULL
LG	NULL
.	NULL

and	NULL
C.D	NULL
.	NULL
)	NULL

from	NULL
the	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
(	NULL
ARC	NULL
6463	NULL
and	NULL
6238	NULL
)	NULL
.	NULL

LL	NULL
.	NULL

is	NULL
a	NULL
fellow	NULL
of	NULL
the	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
(	NULL
LNCC	NULL
)	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

REFERENCES	NULL
.	NULL

Alon	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
D.	NULL
Kassner	NULL
,	NULL
M.	NULL
Woldemar	NULL
Carr	NULL
,	NULL
E.	NULL
B.	NULL
Finger	NULL
,	NULL
M.	NULL
E.	NULL
Helmer	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Springer	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
integrin	NULL
VLA-4	NULL
supports	NULL
tethering	NULL
and	NULL
rolling	NULL
in	NULL
flow	NULL
on	NULL
VCAM-1	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

128:1243-1253.	NULL
.	NULL

Altman	NULL
,	NULL
R.	NULL
,	NULL
D.	NULL
Harrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Garcia	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1988	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
types	NULL
I	NULL
and	NULL
II	NULL
exhibit	NULL
different	NULL
DNase	NULL
I	NULL
protection	NULL
patterns	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

62:1339-1346.	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
Tax	NULL
induces	NULL
cellular	NULL
proteins	NULL
that	NULL
activate	NULL
the	NULL
xB	NULL
clement	NULL
in	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
gene	NULL
.	NULL

Science	NULL
241:1652-1656.	NULL
.	NULL

Beimling	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
K.	NULL
Moelling	NULL
.	NULL

1992	NULL
.	NULL

Direct	NULL
interaction	NULL
of	NULL
CREB	NULL
protein	NULL
with	NULL
21	NULL
bp	NULL
Tax-response	NULL
elements	NULL
of	NULL
HTLV-I	NULL
LTR	NULL
.	NULL

Oncogene	NULL
7:257-262.	NULL
.	NULL

Bevilacqua	NULL
,	NULL
M.	NULL
P.	NULL
1993	NULL
.	NULL

Endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:767-804.	NULL
.	NULL

Briant	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
Coudronni¢re	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
M.	NULL
Benkirane	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1996	NULL
.	NULL

Binding	NULL
of	NULL
HIV-1	NULL
virions	NULL
or	NULL
gp120-anti-gp120	NULL
immune	NULL
complexes	NULL
to	NULL
HIV-1-infected	NULL
quiescent	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
reveals	NULL
latent	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3994-4004.	NULL
.	NULL

Cullen	NULL
,	NULL
B.	NULL
R.	NULL
1992	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
of	NULL
regulatory	NULL
proteins	NULL
encoded	NULL
by	NULL
complex	NULL
retroviruses	NULL
.	NULL

Microbiol	NULL
.	NULL

Rev	NULL
.	NULL

56:375-394.	NULL
.	NULL

Dhawan	NULL
,	NULL
S.	NULL
,	NULL
B.	NULL
S.	NULL
Weeks	NULL
,	NULL
F.	NULL
Abbasi	NULL
,	NULL
H.	NULL
R.	NULL
Gralnick	NULL
,	NULL
A.	NULL
L.	NULL
Notkins	NULL
,	NULL
M.	NULL
E.	NULL
Klotman	NULL
,	NULL
K.	NULL
M.	NULL
Yamada	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Klotman	NULL
.	NULL

1993	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
alpha	NULL
4	NULL
beta	NULL
1	NULL
and	NULL
alpha	NULL
beta	NULL
1	NULL
integrins	NULL
on	NULL
HTLV-I-infected	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
197:778-781.	NULL
.	NULL

Elices	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
L.	NULL
Osborn	NULL
,	NULL
Y.	NULL
Takada	NULL
,	NULL
S.	NULL
Crouse	NULL
,	NULL
M.	NULL
E.	NULL
Luhowskyj	NULL
,	NULL
M.	NULL
E.	NULL
Hemler	NULL
,	NULL
and	NULL
R.	NULL
Lobb	NULL
.	NULL

1990	NULL
.	NULL

VCAM-1	NULL
on	NULL
activated	NULL
endothelium	NULL
interacts	NULL
with	NULL
the	NULL
leukocyte	NULL
integrin	NULL
VLA-4	NULL
at	NULL
a	NULL
site	NULL
distinct	NULL
from	NULL
the	NULL
VLA-4/fibronec-tin	NULL
binding	NULL
site	NULL
.	NULL

Cell	NULL
60:577-584	NULL
.	NULL

Franchini	NULL
,	NULL
G.	NULL
1995	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia/lym-phoma	NULL
virus	NULL
type	NULL
I	NULL
infection	NULL
.	NULL

Blood	NULL
86:3619-3639	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Minamino	NULL
,	NULL
N.	NULL
Masaaki	NULL
,	NULL
M.	NULL
Ken-ichi	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1994	NULL
.	NULL

Serum	NULL
response	NULL
factor	NULL
has	NULL
functional	NULL
roles	NULL
both	NULL
in	NULL
indirect	NULL
binding	NULL
to	NULL
the	NULL
CArG	NULL
box	NULL
and	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
function	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:7275-7283	NULL
.	NULL

Gazzolo	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Duc	NULL
Dodon	NULL
.	NULL

1991	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
events	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
the	NULL
lymphoproliferative	NULL
process	NULL
induced	NULL
by	NULL
HTLV-I	NULL
(	NULL
buman	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
)	NULL
.	NULL

Bull	NULL
.	NULL

Cancer	NULL
(	NULL
Paris	NULL
)	NULL
78:291-298	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
O.	NULL
Gout	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
Thé	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
ii:407-410	NULL
.	NULL

Girerd	NULL
,	NULL
Y.	NULL
,	NULL
H.	NULL
Cassé	NULL
,	NULL
M.	NULL
Duc	NULL
Dodon	NULL
,	NULL
and	NULL
L.	NULL
Gazzolo	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
T	NULL
cell	NULL
leukaemia	NULL
virus	NULL
type	NULL
I	NULL
env	NULL
gene-transfected	NULL
HeLa	NULL
cells	NULL
display	NULL
a	NULL
decrease	NULL
in	NULL
cell	NULL
fusion	NULL
ability	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76:1021-1024	NULL
.	NULL

Higashimura	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Takasawa	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
OX40	NULL
,	NULL
a	NULL
receptor	NULL
of	NULL
gp34	NULL
,	NULL
on	NULL
T	NULL
cells	NULL
by	NULL
transacting	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

87:227-231	NULL
.	NULL

Hildreth	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
A.	NULL
Subramanium	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Hampton	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
-induced	NULL
syncytium	NULL
formation	NULL
mediated	NULL
by	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
:	NULL
evidence	NULL
for	NULL
involvement	NULL
of	NULL
cell	NULL
adhesion	NULL
molecules	NULL
in	NULL
HTLV-1	NULL
biology	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1173-1180	NULL
.	NULL

Hiscott	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
Petropoulos	NULL
,	NULL
and	NULL
J.	NULL
Lacoste	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
interactions	NULL
between	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B/IB	NULL
transcription	NULL
complex	NULL
.	NULL

Virology	NULL
214:3-11	NULL
.	NULL

Hollsberg	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Hafler	NULL
.	NULL

1995	NULL
.	NULL

What	NULL
is	NULL
the	NULL
pathogenesis	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
T-associated	NULL
myelopathy/tropical	NULL
spastic	NULL
para-paresis	NULL
?	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

37:143-145	NULL
.	NULL

Iademarco	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
J.	NULL
Mcquillan	NULL
,	NULL
G.	NULL
D.	NULL
Rosen	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
.	NULL

1992	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16323-16329	NULL
.	NULL

Ichinose	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
A.	NULL
Kawakami	NULL
,	NULL
K.	NULL
Eguchi	NULL
,	NULL
K.	NULL
Nagasato	NULL
,	NULL
K.	NULL
Shibayama	NULL
,	NULL
M.	NULL
Tsujihata	NULL
,	NULL
and	NULL
S.	NULL
Nagataki	NULL
.	NULL

1992	NULL
.	NULL

Increased	NULL
adherence	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
T-associated	NULL
myelopathy	NULL
.	NULL

Arch	NULL
.	NULL

Neurol	NULL
.	NULL

49:74-76	NULL
.	NULL

Ichinose	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Nakamura	NULL
,	NULL
Y.	NULL
Nishiura	NULL
,	NULL
K.	NULL
Nagasato	NULL
,	NULL
K.	NULL
Ohishi	NULL
,	NULL
H.	NULL
Wa-tanabe	NULL
,	NULL
A.	NULL
Fujita	NULL
,	NULL
K.-L.	NULL
Kurouji	NULL
,	NULL
M.	NULL
Tsujibata	NULL
,	NULL
and	NULL
S.	NULL
Nagataki	NULL
.	NULL

1994	NULL
.	NULL

Characterization	NULL
of	NULL
adherent	NULL
T	NULL
cells	NULL
to	NULL
human	NULL
endothelial	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
HTLV-I-associated	NULL
myelopathy	NULL
.	NULL

J.	NULL
Neurol	NULL
.	NULL

Sci	NULL
.	NULL

122:204-209	NULL
.	NULL

Tjichi	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
Eiraku	NULL
,	NULL
M.	NULL
Osame	NULL
,	NULL
S.	NULL
Izumo	NULL
,	NULL
R.	NULL
Kubota	NULL
,	NULL
I.	NULL
Maruyama	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
T.	NULL
Niimura	NULL
,	NULL
and	NULL
S.	NULL
Sonoda	NULL
.	NULL

1989	NULL
.	NULL

Activated	NULL
T	NULL
lymphocytes	NULL
in	NULL
cerebrospinal	NULL
fluid	NULL
of	NULL
patients	NULL
with	NULL
HTLV-T-associated	NULL
myelopathy	NULL
(	NULL
HAM/	NULL
23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Tax-INDUCED	NULL
VCAM-1	NULL
EXPRESSION	NULL
BY	NULL
T	NULL
CELLS	NULL
-	NULL
8529	NULL
TSP	NULL
)	NULL
.	NULL

J.	NULL
Neuroimmunol	NULL
.	NULL

25:251-254	NULL
.	NULL

Imura	NULL
,	NULL
A.	NULL
,	NULL
T.	NULL
Hori	NULL
,	NULL
K.	NULL
Imada	NULL
,	NULL
T.	NULL
Ishikawa	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
M.	NULL
Maeda	NULL
,	NULL
S.	NULL
Imamura	NULL
,	NULL
and	NULL
T.	NULL
Uchiyama	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
human	NULL
OX40/gp34	NULL
system	NULL
directly	NULL
mediates	NULL
adhesion	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
to	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:2185-2195	NULL
.	NULL

Iwasaki	NULL
,	NULL
I	NULL
.	NULL

1990	NULL
.	NULL

Pathology	NULL
of	NULL
chronic	NULL
myelopathy	NULL
associated	NULL
with	NULL
HTLV-I	NULL
infection	NULL
(	NULL
HAM/TSP	NULL
)	NULL
.	NULL

J.	NULL
Neurol	NULL
.	NULL

Sci	NULL
.	NULL

96:103-123.	NULL
.	NULL

Jacobson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
E.	NULL
McFarlin	NULL
,	NULL
S.	NULL
Robinson	NULL
,	NULL
R.	NULL
Voskuhl	NULL
,	NULL
R.	NULL
Martin	NULL
,	NULL
A.	NULL
Bre-wah	NULL
,	NULL
A.	NULL
J.	NULL
Newell	NULL
,	NULL
and	NULL
S.	NULL
Koenig	NULL
.	NULL

1992	NULL
.	NULL

HTLV-I-specific	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
in	NULL
the	NULL
cerebrospinal	NULL
fluid	NULL
of	NULL
patients	NULL
with	NULL
HTLV-	NULL
[	NULL
-associated	NULL
neurological	NULL
disease	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

32:651-657	NULL
.	NULL

Leca	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
E.	NULL
Mansur	NULL
,	NULL
and	NULL
A.	NULL
Bensussan	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
VCAM-1	NULL
(	NULL
CD106	NULL
)	NULL
by	NULL
a	NULL
subset	NULL
of	NULL
TCR	NULL
y8-bearing	NULL
lymphocyte	NULL
clones	NULL
.	NULL

Involvement	NULL
of	NULL
a	NULL
metalloprotease	NULL
in	NULL
the	NULL
specific	NULL
hydrolytic	NULL
release	NULL
of	NULL
the	NULL
soluble	NULL
isoform	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:1069-1077	NULL
.	NULL

Lemasson	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Briant	NULL
,	NULL
B.	NULL
Hague	NULL
,	NULL
N.	NULL
Coudronni¢re	NULL
,	NULL
L.	NULL
Heron	NULL
,	NULL
C.	NULL
David	NULL
,	NULL
C.	NULL
Rebouissou	NULL
,	NULL
T.	NULL
Kindt	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
antibody	NULL
that	NULL
binds	NULL
domain	NULL
1	NULL
of	NULL
CD4	NULL
inhibits	NULL
replication	NULL
of	NULL
HIV-1	NULL
,	NULL
but	NULL
not	NULL
HTLV-I	NULL
,	NULL
in	NULL
a	NULL
CD4-positive/	NULL
pSélck-negative	NULL
HTLV-I-transformed	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:859-865	NULL
.	NULL

Lemasson	NULL
,	NULL
I.	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
S.	NULL
Hamaia	NULL
,	NULL
M.	NULL
Duc	NULL
Dodon	NULL
,	NULL
L.	NULL
Gazzolo	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1997	NULL
.	NULL

Transrepression	NULL
of	NULL
Ick	NULL
gene	NULL
expression	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1-encoded	NULL
p40	NULL
``	NULL
*	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:1975-1983	NULL
.	NULL

Leon-Monzon	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Ila	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Dalakas	NULL
.	NULL

1994	NULL
.	NULL

Polymyositis	NULL
in	NULL
patients	NULL
infected	NULL
with	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
virus	NULL
in	NULL
the	NULL
cause	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Ann	NULL
.	NULL

Neurol	NULL
.	NULL

36:643-649	NULL
.	NULL

Lobb	NULL
,	NULL
R.	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Hemler	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
pathophysiologic	NULL
role	NULL
of	NULL
«	NULL
4	NULL
integrins	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

94:1722-1728	NULL
.	NULL

Miyoshi	NULL
,	NULL
I.	NULL
,	NULL
I.	NULL
Kubonishi	NULL
,	NULL
S.	NULL
Yoshimoto	NULL
,	NULL
T.	NULL
Akagi	NULL
,	NULL
Y.	NULL
Ohtsuki	NULL
,	NULL
Y.	NULL
Shiraishi	NULL
,	NULL
K.	NULL
Nagata	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1981	NULL
.	NULL

Type	NULL
C	NULL
virus	NULL
particles	NULL
in	NULL
a	NULL
cord	NULL
T-cell	NULL
line	NULL
derived	NULL
by	NULL
co-cultivating	NULL
normal	NULL
human	NULL
cord	NULL
leukocytes	NULL
and	NULL
human	NULL
leukae-mic	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
294:770-771	NULL
.	NULL

Mori	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
S.	NULL
Oda	NULL
,	NULL
and	NULL
S.	NULL
Eto	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
induces	NULL
intracellular	NULL
adhesion	NULL
molecule-1	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
84:350-351	NULL
.	NULL

Moynagh	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
D.	NULL
C.	NULL
Williams	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
J.	NULL
O'Neill	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
induction	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
intracellular	NULL
adhesion	NULL
molecule-1	NULL
expression	NULL
in	NULL
human	NULL
glial	NULL
cells	NULL
by	NULL
IL-1	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:2681-2689	NULL
.	NULL

Munoz	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Courtois	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
P.	NULL
Jalinot	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
through	NULL
dissociation	NULL
of	NULL
cytoplasmic	NULL
complexes	NULL
containing	NULL
p105	NULL
or	NULL
p100	NULL
but	NULL
does	NULL
not	NULL
induce	NULL
degradation	NULL
of	NULL
IxBa/MAD3	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:8035-8044	NULL
.	NULL

Nagata	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Ohtani	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
and	NULL
K.	NULL
Sugamura	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
endogenous	NULL
c-fos	NULL
proto-oncogene	NULL
expression	NULL
by	NULL
human	NULL
T-cell-leukemia-vi-rus-type	NULL
I-encoded	NULL
p40tax	NULL
protein	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
line	NULL
,	NULL
Jurkat	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3220-3226	NULL
.	NULL

Neish	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
A.	NULL
J.	NULL
Williams	NULL
,	NULL
H.	NULL
J.	NULL
Palmer	NULL
,	NULL
M.	NULL
Z.	NULL
Whitley	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1583-1593	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
C.	NULL
A.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
O.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5	NULL
:	NULL
444-447	NULL
.	NULL

Nyborg	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
W.	NULL
S.	NULL
Dynan	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
and	NULL
W.	NULL
Wachsman	NULL
.	NULL

1988	NULL
.	NULL

Binding	NULL
of	NULL
host-cell	NULL
factors	NULL
to	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
gene	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:1457-1461	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
S.	NULL
Isumo	NULL
,	NULL
N.	NULL
Tjichi	NULL
,	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Matsumoto	NULL
,	NULL
and	NULL
H.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-I	NULL
associated	NULL
myelopathy	NULL
:	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
1031-1032	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
C.	NULL
Tizard	NULL
,	NULL
S.	NULL
Vassallo	NULL
,	NULL
S.	NULL
Luhowskyj	NULL
,	NULL
G.	NULL
Chi-Rosso	NULL
,	NULL
and	NULL
R.	NULL
Lobb	NULL
.	NULL

1989	NULL
.	NULL

Direct	NULL
expression	NULL
cloning	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
,	NULL
a	NULL
cytokine-induced	NULL
endothelial	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
59:1203-1211	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
F.	NULL
W.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
F.	NULL
Gazdar	NULL
,	NULL
P.	NULL
A.	NULL
Bunn	NULL
,	NULL
J.	NULL
D.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type-C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
patients	NULL
with	NULL
cutancous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Postigo	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
Teixido	NULL
,	NULL
and	NULL
F.	NULL
Sanchez-Madrid	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
alpha	NULL
4	NULL
betal/	NULL
VCAMI1	NULL
adhesion	NULL
pathway	NULL
in	NULL
physiology	NULL
and	NULL
disease	NULL
.	NULL

Res	NULL
.	NULL

Immunol	NULL
.	NULL

144	NULL
:	NULL
723-730	NULL
.	NULL

Rosen	NULL
,	NULL
G.	NULL
D.	NULL
,	NULL
J.	NULL
R.	NULL
Sanes	NULL
,	NULL
R.	NULL
LaChance	NULL
,	NULL
J.	NULL
M.	NULL
Cunningham	NULL
,	NULL
J.	NULL
Roman	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
.	NULL

1992	NULL
.	NULL

Roles	NULL
for	NULL
the	NULL
integrin	NULL
VLA-4	NULL
and	NULL
its	NULL
counter	NULL
receptor	NULL
VCAM-1	NULL
in	NULL
myogenesis	NULL
.	NULL

Cell	NULL
69:1107-1119	NULL
.	NULL

Salahuddin	NULL
,	NULL
S.	NULL
Z.	NULL
,	NULL
P.	NULL
D.	NULL
Markham	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
G.	NULL
Franchini	NULL
,	NULL
V.	NULL
S.	NULL
Kalyaraman	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Gallo	NULL
.	NULL

1983	NULL
.	NULL

Restricted	NULL
expression	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia-lymphoma	NULL
virus	NULL
(	NULL
HTLV	NULL
)	NULL
in	NULL
transformed	NULL
human	NULL
umbilical	NULL
cord	NULL
blood	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
129:51-64	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
R.	NULL
Grassmann	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
.	NULL

1992	NULL
.	NULL

Antioxidants	NULL
selectively	NULL
suppress	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6288-6293	NULL
.	NULL

Shu	NULL
,	NULL
H.	NULL
B.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Agranoff	NULL
,	NULL
E.	NULL
G.	NULL
Nabel	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
A.	NULL
S.	NULL
Neish	NULL
,	NULL
T.	NULL
Collins	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
vascular	NULL
cell	NULL
8530	NULL
47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

VALENTIN	NULL
ET	NULL
AL	NULL
.	NULL

adhesion	NULL
molecule	NULL
1	NULL
gene	NULL
expression	NULL
by	NULL
specific	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
in	NULL
endothelial	NULL
and	NULL
epithelial	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6283-6289	NULL
.	NULL

Sodroski	NULL
,	NULL
J	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
(	NULL
HTLV	NULL
)	NULL
transactivator	NULL
(	NULL
Tax	NULL
)	NULL
protein	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1114:19-29	NULL
.	NULL

Springer	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
76:301-314	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
C.	NULL
Elwwod	NULL
,	NULL
C.	NULL
Béraud	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

involves	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mediated	NULL
induction	NULL
of	NULL
the	NULL
c-rel	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7377-7384	NULL
.	NULL

Takatsuki	NULL
,	NULL
K.	NULL
,	NULL
T.	NULL
Uchiyama	NULL
,	NULL
K.	NULL
Sagawa	NULL
,	NULL
and	NULL
J.	NULL
Yodoi	NULL
.	NULL

1977	NULL
.	NULL

Adult	NULL
T	NULL
cell	NULL
leukemia	NULL
in	NULL
Japan	NULL
,	NULL
p.	NULL
73-75	NULL
.	NULL

In	NULL
Topics	NULL
in	NULL
Hematology	NULL
,	NULL
Proceedings	NULL
of	NULL
the	NULL
16th	NULL
International	NULL
Congress	NULL
of	NULL
Hematology	NULL
.	NULL

Excerpta	NULL
Medica	NULL
,	NULL
Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Fukudome	NULL
,	NULL
M.	NULL
Hayashi	NULL
,	NULL
S.	NULL
Takagi	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
ICAM-1	NULL
and	NULL
LFA-3	NULL
by	NULL
Tax1	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
mechanism	NULL
of	NULL
down-regulation	NULL
of	NULL
ICAM-1	NULL
or	NULL
LFA-1	NULL
in	NULL
adult-T-cell	NULL
leukemia	NULL
cell	NULL
lines	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
60:554-561	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

Tanaka	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Hayashi	NULL
,	NULL
S.	NULL
Takagi	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
transactivation	NULL
of	NULL
the	NULL
intercellular	NULL
adhesion	NULL
molecule	NULL
1	NULL
gene	NULL
promoter	NULL
by	NULL
Taxl	NULL
and	NULL
Tax2	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
viruses	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:8508-8517	NULL
.	NULL

Tatewaki	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Yamaguchi	NULL
,	NULL
M.	NULL
Matsuoka	NULL
,	NULL
T.	NULL
Ishii	NULL
,	NULL
M.	NULL
Miyasaka	NULL
,	NULL
S.	NULL
Mori	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
T.	NULL
Watanabe	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
overexpression	NULL
of	NULL
the	NULL
L-selectin	NULL
gene	NULL
in	NULL
fresh	NULL
leukemic	NULL
cells	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
that	NULL
can	NULL
be	NULL
transactivated	NULL
by	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
.	NULL

Blood	NULL
86	NULL
:	NULL
3109-3117	NULL
.	NULL

Uchiyama	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Yodoi	NULL
,	NULL
K.	NULL
Sagawa	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
H.	NULL
Uchino	NULL
.	NULL

1977	NULL
.	NULL

Adult	NULL
T-cell	NULL
leukemia	NULL
:	NULL
clinical	NULL
and	NULL
hematological	NULL
features	NULL
of	NULL
16	NULL
cases	NULL
.	NULL

Blood	NULL
50:481-492	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

HTLV-1	NULL
oncoprotein	NULL
Tax	NULL
deregulates	NULL
transcription	NULL
of	NULL
cellular	NULL
genes	NULL
through	NULL
multiple	NULL
mechanisms	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

Clin	NULL
.	NULL

Oncol	NULL
.	NULL

121:521-528	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
I.	NULL
Miyoshi	NULL
,	NULL
and	NULL
Y.	NULL
Hinuma	NULL
.	NULL

1982	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
retroviruses	NULL
from	NULL
cell	NULL
lines	NULL
of	NULL
human	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
its	NULL
implication	NULL
in	NULL
the	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
79:2031-2035	NULL
.	NULL

